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PhD abstract 
 
Delta-like homologue 1 (Dlk1) and Dlk2 encode vertebrate-specific transmembrane proteins 
belonging to the Jagged/Delta/Serrate family of Notch ligands. Murine Dlk1 is widely expressed 
during embryonic development and targeted deletion results in defects in numerous 
developmental processes, such as adipogenesis, haematopoiesis, neurogenesis and skeletal muscle 
formation. However, the mechanisms by which DLK1 regulates these processes remains unclear. 
The purpose of this project is to examine the function of these genes using zebrafish as an in vivo 
model, allowing insight to the ancestral functions of these genes. We have strong evolutionary 
evidence that dlk2 is the ancestral version of the gene from which dlk1 is derived; therefore, the 
thesis focuses primarily on the role of dlk2 in the zebrafish system. 
  I initially examine the expression of zebrafish dlk1 and dlk2 during embryonic 
development and in the adult brain, determining similarities and differences between mouse and 
zebrafish. In particular, dlk1 and dlk2 in the fish exhibit a pattern that is more reminiscent of Dlk2 
in the mouse. This developmental expression pattern is essential for the interpretation of the 
modulation of Dlk2 in later chapters, and is aided by the generation of a mammalian Dlk2 antibody 
that cross-reacts with zebrafish. We obtained a dlk2 mutant and used this line to examine the role 
of the DLK2 protein in development and in the adult brain. I demonstrate that, in the absence of 
DLK2, a population of neural precursor cells appear to over-proliferate early in zebrafish 
development. Later, by larval stages, these cells are absent, suggesting a premature activation and 
subsequent depletion of the progenitor cell pool in the mutant, reminiscent of the Dlk1 mutant in 
mouse. Associated with this phenotype are larval behavioral defects in motor response. In this 
thesis, it will be shown that in the adult dlk2 mutant zebrafish, the radial glial cell population in the 
telencephalon is completely depleted. These radial glial cells are thought to be responsible for adult 
neural regeneration in zebrafish, and our characterization of a mutant completely lacking this cell 
population provides a rich model to further examine and understand the functions of this well-
	 4	
studied but poorly understood cell population. These findings have both functional and 
evolutionary implications for the relative roles of these two vertebrate specific atypical Notch 
ligands.  
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1. Introduction 
	
The gene Dlk1 is known to have numerous functions during mouse development. While this gene 
has been extensively studied and has been shown to regulate many processes, the mechanisms via 
which it functions are largely unknown and have so far been difficult to elucidate and confirm 
using the mouse model. Murine Dlk1 has a juxtamembrane cleavage site that allows it to be 
secreted. Alternative splicing of Dlk1 leads to this site being either included or excluded from the 
mature transcript, hence resulting in different transcripts that are either secreted or membrane-
bound. The different isoforms of the DLK1 protein have different functions during development, 
which makes understanding their function and mechanisms of function in vivo very challenging. 
Murine Dlk1 has also been co-opted into numerous mammalian specific functions, and is regulated 
as part of an imprinted cluster, potentially making it easier to understand basal mechanisms of 
function in a non-mammalian system. A similar gene, Dlk2, has also been described. It is 
structurally very similar to Dlk1, but currently very little is known about its function. However, 
evolutionary analysis suggests that Dlk2 is the ancestral gene from which Dlk1 is derived. This 
project aims to examine dlk1 and dlk2 in zebrafish to establish a model system in which it will be 
possible to elucidate the currently unknown mechanisms by which these genes operate.  
 This chapter presents an overview of what is currently known about these genes, starting 
with their structure and evolution. Current knowledge about the expression of Dlk1 in mouse will 
be explained as well as compared to dlk1 expression in zebrafish, in both development and post-
natal life. Particular attention will be paid to the known functions of Dlk1 and its role in stem cell 
regulation.  It is hypothesized that the regulation of stem cells may represent the conserved and 
ancestral functions of these genes, as opposed to the highly mammalian functions Dlk1 performs 
in mouse. Therefore, these examples provide a useful context in which to examine the possible 
roles these genes play in zebrafish, and to interpret the results presented in this thesis.  The known 
neo-functionalism observed in the murine system is examined in order to provide further 
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understanding of these genes, but also to demonstrate the difficulty of examining these genes 
within the murine system. The zebrafish system is introduced as an ideal model to examine the 
function of these genes. The chapter is concluded with a summary of the hypotheses addressed in 
this thesis.  
 
1.1 The protein structures of murine DLK1 and DLK2  
 
Delta-like homologue 1 (Dlk1) encodes a vertebrate-specific transmembrane protein which 
belongs to the Jagged/Delta/Serrate family of Notch ligands (Bray et al., 2008; Ferrón et al., 2011). 
Proteins in this family typically contain a series of Epidermal Growth Factor (EGF)-like repeats 
and a Delta-Serrate-Lag2 (DSL) domain at the N terminus. The DSL domain is thought to be the 
domain which interacts with the EGF-like repeats of Notch proteins (Cordle et al., 2008). Dlk1 
contains six of these tandemly repeated EGF-like motifs; however, these lack the conserved 
residues thought to be required for binding to EGF receptors (Laborda et al., 1993; Sul, 2009). 
Instead, the two most N-terminal EGF-like repeats of the DLK1 protein are a conserved DOS 
(Delta and OSM-11) motif, shared by the classic Notch ligands (Kopan and Ilagan, 2009). Dlk1 
significantly differs from the other members of this family in two main aspects: it has a short 
intracellular domain and no DSL domain (Bray et al., 2008) (Fig. 1.1A). In Drosophila, Delta 
proteins with similarly truncated intracellular domains act as dominant-negative forms of Notch 
ligands (Sun and Artavanis-Tsakonas, 1996). DLK1 contains a juxtamembrane motif that can be 
cleaved by extracellular proteases. In eutherian mammals, alternative splicing creates different 
transcripts encoding four different protein isoforms (Fig. 1B). There are two secreted isoforms 
that contain the motif (A and B), and two that do not contain the protein cleavage site and as such 
remain membrane-bound (C and D) (Bray et al., 2008). These isoforms have been shown to play 
different developmental roles (Baisong Mei, 2002; Ferrón et al., 2011).   
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1.2 Evolution of of DLK1 and DLK2 in vertebrates 
 
1.2.1 Dlk2 is the ancestral gene and highly conserved among the vertebrate species 
 
Delta-like originally arose from the duplication of Delta at some point before the divergence of 
Ciona from the rest of the chordate lineages (Fig. 1.1B, pers. comm. Carol Edwards). A subsequent 
duplication produced Dlk1 and Dlk2. Dlk2 is much more highly conserved than Dlk1 in all species 
examined. In Ciona, where there is only one Dlk gene, it is more similar to mammalian Dlk2 than 
to Dlk1, suggesting that this is the ancestral form.  
 
1.2.2 Zebrafish dlk1 lacks the sequence for the cleavage domain. 
  
Zebrafish have a single copy of both dlk1 and dlk2, but zebrafish dlk1 is highly divergent to Dlk1 
examined in all other species (Fig 1.1B). Zebrafish dlk1 lacks the sequence for the extracellular 
cleavage site and so remains tethered to the membrane. Dlk2, on the other hand, still contains the 
cleavage site (Fig.1.1C). Comparing their protein structure demonstrates the similarity between 
these proteins and also clearly shows the loss of the juxtamembrane cleavage site (Fig. 1.2). 
 
1.3 Murine Dlk1  
	
1.3.1 Dlk1 expression during embryonic development 
	
Dlk1 has been examined at E10, E12.5 and E16.5 and is clearly widely expressed during early 
embryonic development. The period between E12.5 and E16.5 marks the period of reduced Dlk1 
expression. In postnatal mice, it is isolated to a few specific tissues; in the brain, this includes the 
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nucleus accumbens, the sub-ventricular zone and several areas of the hypothalamus (da Rocha et 
al., 2007; Yevtodiyenko and Schmidt, 2006). 
 Between E10 and E16.5, Dlk1 is expressed in tissues derived from the ectodermal, 
mesodermal, endodermal cells layers, as well as extra-embryonic tissues. In ectodermally-derived 
tissues, Dlk1 is isolated to a few specific locations, such as the thalamus, hypothalamus and the 
optic recess (da Rocha et al., 2007). Dlk1 is prominently expressed in the Rathke’s pouch from 
E10 to E13, which then forms the anterior lobe of the developing pituitary gland. At E15, Dlk1 is 
expressed in the mature pituitary gland in the anterior lobe but also more strongly expressed in the 
independently-derived posterior lobe.  In contrast to its expression in the ectoderm, Dlk1 is more 
broadly expressed in the mesoderm during murine embryonic development. At E10, Dlk1 is 
expressed in the myotomes and the sclerotome of the somites, and is expressed in skeletal muscle 
and cartilage until birth (da Rocha et al., 2007). The tongue is one of the most highly Dlk1 
expressing tissues at E12.5 and this expression is maintained, as with the other skeletal muscle 
expression, through E16.5 until birth (Yevtodiyenko and Schmidt, 2006). Dlk1 is expressed in 
most undifferentiated mesenchyme at this early stage (Yevtodiyenko and Schmidt, 2006). In 
endodermally-derived tissues, Dlk1 is most strongly expressed in the lung and in the liver. In the 
developing liver, Dlk1 is highly expressed in the hepatic cells. In the lung, Dlk1 is expressed in the 
segmental bronchi and surrounding mesenchyme at E12.5. By E16.5, there is a reduction of Dlk1 
expression in the lung but it remains in the epithelium of the terminal bronchioles (Yevtodiyenko 
and Schmidt, 2006). Dlk1 is also expressed in the pancreas and the ducts of the adrenal gland (da 
Rocha et al., 2007). Dlk1 is expressed throughout extraembryonic tissues, including the chorionic 
plate, yolk sac and placenta (da Rocha et al., 2007). Dlk1 is also expressed in all three layers of the 
placenta: the labyrinthine zone, junctional zone and decidua basalis (da Rocha et al., 2007)  
Dlk1 is most likely expressed in more locations than has currently been described in these 
gross morphological studies. As will be described in Section 1.4, Dlk1 is also expressed in 
numerous stem cell and progenitor cell populations, playing a key role in the differentiation and 
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proliferative states of these cells. These discrete cell populations mostly likely account for the 
majority of Dlk1 expression in the postnatal and adult mouse. 
 
1.3.2 Development of the Dlk1 mutant mouse  
 
Given the expression of Dlk1 throughout all the different germ-layer derived tissues, and its key 
roles in stem cell regulation (Section 1.4), it is worth noting that Dlk1-null mice are homozygous 
viable from zygotic mutants. The Dlk1 mutant mice were found to be growth retarded, with female 
mutant mice weighing an average of 7.34g and males weighing 7.58g, compared to the wild type 
averages of 8.51g and 8.81g, respectively (Moon et al., 2002). In addition, when fed on a high-fat 
diet, the level of adipose deposition in white fat pads was increased in mutant mice relative to the 
wild type in both males and females. By examining differentiation markers in the adipose tissue, it 
was determined that increased levels of pre-adipocyte differentiation were responsible for the 
increased level of fat pad weights (Moon et al., 2002). This is in line with the proposed role of 
Dlk1 in adipogenesis (Section 1.4.1). Overall, the gross morphological effects of losing Dlk1 are 
not as dramatic as might be expected. The Dlk1-null mouse has been used to examine specific 
roles of Dlk1 in different cell populations and to study Dlk1 as a stem cell regulator, described in 
Section 1.4.   
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1.4 Dlk1 as a stem cell regulator  
 
1.4.1 Dlk1 in adipogenesis 
 
During adipogenesis, Dlk1 is highly expressed in pre-adipocytes and is then down-regulated during 
differentiation into adipocytes, being completely absent in the mature adipocyte. In vitro, the 
presence of Dlk1 inhibits differentiation of pre-adipocytes into adipocytes (Smas and Sul, 1993). 
To demonstrate this, Dlk1 was expressed in 3T3-L1 cells, a pre-adipocyte cell line, using a 
constitutively active expression plasmid with Dlk1 cDNA. The markers of mature adipocytes were 
examined, showing a reduction in adipogenesis in the Dlk1 expressing cells in vitro compared to 
the empty control vector (Wang et al., 2006). The same system was used to explore the effect of 
only expressing one of each of the four isoforms (outlined in section 1.1). The result of the 
isoforms is a protein that is either tethered to the membrane or able to be secreted because of the 
inclusion of the extra-cellular cleavage site. This experiment demonstrated that only the isoforms 
able to produce the large soluble form of Dlk1 (DLK1A and DLKB) display the inhibitory role 
on adipogenesis. The isoforms that are membrane-tethered had no effect on the differentiation of 
3T3-L1 cells into mature adipocytes in vitro (Wang et al., 2006). This demonstrates that the secreted 
isoform and the membrane-bound isoform perform distinct developmental roles. As predicted 
from the in vitro results, the Dlk1 mutant mice have increased levels of obesity (Moon et al., 2002). 
This is assumed to be as a result of losing the secreted DLK1 protein, but as both are expressed 
from the same deleted gene locus, it is impossible to definitively identify which isoform is 
responsible. 
 
1.4.2 Dlk1 in haematopoietic stem cells 
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Dlk1 is known to be expressed in the major sites of haematopoiesis in the developing embryo, 
such as the placenta and the liver (See section 1.3.1). In order to examine the possible role of Dlk1 
in haematopoiesis, the number of hematopoietic stem cells (HSCs) was examined in vivo in the wild 
type, the dlk1 mutant and in a transgenic mouse that expresses an extra copy of dlk1 from a 
different genetic locus but under the control of the endogenous dlk1 promoter (Mirshekar-Syahkal 
et al., 2013). The aorta-gonad-mesonephros (AGM) is an important site of HSC production during 
definitive haematopoiesis, starting at E10 (Dieterlen-Lievre, 1975).  The AGM was examined at 
E11.5, and absence of Dlk1 led to an increase in the number of haematopoietic stem and 
progenitor cells present, with a similar decrease observed in the transgenic Dlk1 over-expressing 
embryo. Tunnel assays and Ki67 staining were performed to investigate apoptosis and 
differentiation, respectively, and demonstrated that, in the Dlk1 mutant, there were increased levels 
of the differentiation marker and the differences in cell populations between the conditions were 
not because of apoptosis levels. The number of HSCs in the mutant or transgenic AGM was not 
altered (Mirshekar-Syahkal et al., 2013). Taken together, this demonstrates that Dlk1 is negatively 
regulating the differentiation of HSCs, as it does with pre-adipocytes.   
 
1.4.3 Dlk1 in neural progenitor development 
 
The role Dlk1 plays in mammalian embryonic neurogenesis was assessed using an in vitro model. 
Embryonic stem cells (ESCs) were differentiated into neural progenitor cells (Surmacz et al., 2011). 
In the wild-type, Dlk1 expression corresponded with the expression of the pro-neural genes Mash1 
and NeuroD. To examine the role of Dlk1, a tamoxifen-induced Dlk1 expression construct was 
used to up-regulate Dlk1 levels in the differentiating cell population. In this context, the up-
regulation of Dlk1 led to an increase in neural differentiation, using p57Kip2 as a differentiation 
marker (Surmacz et al., 2011). This same effect was observed if the medium from the Dlk1 over-
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expressing cells was used to culture wild-type ESC-derived neural progenitor cells, suggesting this 
process is mediated by the secreted isoform of Dlk1.  
 
1.4.4 Dlk1 in adult neurogenesis  
 
Neural stem cells (NSCs) are not only present in the embryonic mouse, but also in isolated areas 
of the adult brain. In particular, NSCs have been found in the subventricular zone (SVZ) and the 
hippocampus (Ma et al., 2009). A recent study found that while mouse Dlk1 is dispensable for 
neurogenesis, it is important for maintaining NSC populations in the neurogenic niche of the SVZ 
(Ferrón et al., 2011). As the Dlk1-null mutant animals age, the amount of primary neuroblasts 
decrease because the NSC pool is not properly maintained. NSCs were isolated from the post-
natal mouse, and it was shown that applying recombinant DLK1 to the medium led to an increased 
number of neurospheres being produced from these wild type NSC cultures. The neurosphere 
assay is an established technique to assess NSCs, and the neurospheres are a heterogeneous 
population of NSC progeny (Reynolds and Rietze, 2005) However, neurosphere production by 
NSCs derived from the Dlk1-null mouse did not increase with the addition of recombinant DLK1 
(Ferrón et al., 2011). By specifically expressing the membrane-bound Dlk1 or the secreted Dlk1 in 
the Dlk1-null NSCs, it was demonstrated that the NSCs need to express the membrane-bound 
form of DLK1 in order for the recombinant DLK1 in the media to cause an increase in the 
neurosphere production. In the SVZ, the NSCs are surrounded by niche astrocytes, and it was 
hypothesized that these could be the in vivo source of the secreted DLK1. Co-culture experiments 
with NSC and dlk1-null niche astrocytes transfected with the different isoforms of Dlk1 
demonstrated that the expression of the secreted form of DLK1 from the niche astrocytes 
increased the neurosphere production in wild type NSCs (Ferrón et al., 2011). 
 In summary, the niche astrocytes normally regulate NSC proliferation and differentiation 
into neuroblasts by expressing the secreted form of Dlk1. However, this signal can only be received 
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by NSCs if they are expressing the membrane-bound form of Dlk1 (Ferrón et al., 2011) This raises 
a series of questions regarding the relationship between the membrane-bound and secreted 
isoforms, receptor-ligand interactions, and the signaling pathways of the different isoforms. 
Deciphering these questions in vivo in mouse is difficult, because it is challenging to modulate the 
different isoforms separately as they are expressed from the same gene locus. 
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1.5 Dlk1 mammalian neofunctionalism 
	
1.5.1. Dlk1 has roles in mammalian-specific functions 
 
One of the largest challenges a mammal faces is the transition to independent life. One of the key 
process involved with this transition is the shift in their metabolic mode from lipolytic to lipogenic, 
in order to allow the digestion of solid food and storing excess energy as fat (Herrera and 
Amusquivar, 2000). In addition, the animal must be able to regulate its own body temperature in 
order to survive away from the nest. In post-natal mice, the majority of temperature regulation is 
generated via non-shivering thermogenesis (NST). NST is dependent on brown adipose tissue 
(BAT) (CANNON and Nedergaard, 2004).  Relatively small increases in Dlk1 dosage have recently 
been shown to impair differentiation of BAT. This means that NST does not occur properly, 
which in turn has a large impact on neonatal survival (Charalambous et al., 2012). This suggests 
that correct levels of Dlk1 expression are very important for maintaining normal development; in 
mammals, this is achieved by imprinting. Many imprinted genes have been shown to regulate 
postnatal metabolic processes and have effects on mammalian physiological and metabolic 
adaptations (Charalambous et al., 2007).  
 Pregnancy is a time of massive metabolic change, with the female being able to adjust her 
own metabolism to maintain a constant supply of nutrients to the fetus even with changing food 
availability. It has been demonstrated that in the lead up to birth there is a large increase in levels 
of secreted DLK1 protein circulating in the mother’s blood (Bachmann et al., 1996). Recently, it 
has been shown that secreted DLK1 protein in the mother’s circulation is derived from the 
developing embryo  (Cleaton et al., 2016). It was then demonstrated that the maternal expression 
of Dlk1 was required in order to interpret the metabolic signal of the fetal DLK1. This is a highly 
mammalian-specific process of signaling between the conceptus and the mother with the use of a 
gene regulated by imprinting (Cleaton et al., 2016).   
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1.5.2 Dlk1 is regulated as part of the Dlk1-Dio3 imprinted cluster 
 
In mouse, Dlk1 is located within the Dlk1-Dio3 imprinted cluster on chromosome 12, which is 
controlled by the intergenic differentially methylated region (IG-DMR) (de Rocha et al., 2008). It 
is expressed from the imprinted paternal chromosome, and transcription is repressed on the 
maternal chromosome due to the unmethylated IG-DMR (Edwards et al., 2008). Dlk1 is dosage-
sensitive and if imprinting is removed, effectively resulting in a double dose, it leads to high levels 
of lethality and tissue-specific growth enhancement, with reciprocal levels of growth retardation 
in Dlk1-null mice (da Rocha et al., 2009; Moon et al., 2002). 
 
The fact that Dlk1 is part of an imprinted cluster and regulates BAT development, expression 
throughout all the mammalian-specific extra embryonic tissues, as well as circulating DLK1 
derived from the conceptus, suggests that it has been co-opted into numerous mammalian specific 
processes.   
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1.6 Dlk2 in mouse 
	
Dlk2 was first described in 2007 when a detailed search looking for similar genes to Dlk1 was 
performed on the published mouse genome (Nueda et al., 2007). It was found to have a similar 
sequence and protein structure to Dlk1 (described in Section 1.1). Analysis of the Dlk2 sequence 
in mouse and its comparison to other vertebrates suggests that Dlk2 is much better conserved 
across the phylum and is potentially the ancestral form from which Dlk1 arose (C. Edwards pers. 
Comm., discussed in Section 1.1). Very little is known about the function of Dlk2. In the study by 
Nueda et al. in which it was originally described, 3T3-L1 pre-adipocytes, known to be regulated by 
Dlk1 (Section 1.4.1), were transfected with expression constructs expressing the sense or anti-
sense orientation of Dlk2. This study suggests that over-expression of Dlk2 does not affect 
differentiation of the pre-adipocytes, but expression of the anti-sense orientation Dlk2 leads to a 
decrease in mature adipocyte markers. The authors suggest that this implicates Dlk2 as a regulator 
of adipogenesis (Nueda et al., 2007). However, the authors provide no evidence that the expression 
of the anti-sense Dlk2 leads to a reduction in DLK2 protein, and has no effect on the levels of 
other genes, such as the similar sequence of Dlk1. It is therefore not possible to draw conclusions 
about the function of Dlk2 from this study.  The project described in this thesis will be a first study 
of the function of endogenous Dlk2 in an in vivo system.  
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1.7 Known mechanisms of Dlk1 and Dlk2 function. 
	
1.7.1 Dlk1 and Dlk2 as regulators of the Notch signalling pathway 
 
Dlk1 and Dlk2 contain an EGF-like tandem repeat motif shared with classic Notch ligands. 
However, as previously described in Section 1.1, they lack domains thought to be essential for 
interaction with Notch receptors; their intracellular domain is truncated and their DSL domain is 
entirely lacking (Fig. 1A). This would suggest that Dlk1 would have lost its ability to act as a Notch 
ligand. However, evidence from yeast two-hybrid experiments suggests that Dlk1 interacts with 
Notch through its EGF-like repeats (Baladrón et al., 2005). Furthermore, when murine Dlk1 is 
expressed in Drosophila, it acts to inhibit Notch signaling, whereas the typical mouse Delta ligands 
Dll1 and Dll4 are able to activate Drosophila Notch signaling (Bray et al., 2008). This suggests that 
it is possible that Dlk1 can mediate the Notch signaling pathway despite its lack of functional 
domains. Further evidence of Dlk1 mediating Notch signaling is in the examination of Dlk1 and 
its ability to promote neurogenesis of neural progenitors derived from ESCs (Surmacz et al., 2011). 
They show that the over-expression of Dlk1 leads to higher levels of differentiation in the ESC-
derived neural progenitors. When they compare Notch signaling between the control and the 
Dlk1-overexpression cell populations, they see a decrease in downstream Notch targets (Surmacz 
et al., 2011). However, they demonstrate that the control and the Dlk1 treatment group have 
different cell compositions; therefore, the changes in Notch signaling could be due to the relative 
expression of downstream Notch targets in the different cell populations, rather than a direct result 
of Dlk1 signaling.  The examination of Dlk1 or Dlk2 function through Notch signaling has not 
been examined properly in an in vivo endogenous system.  
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1.7.2 Dlk1 as a regulator of non-Notch dependant processes 
 
While the evidence that Dlk1 operates through Notch signalling is yet to be conclusively shown, 
it is clear that Dlk1 can also operate through non-Notch signalling pathways. A study using the 
3T3-L1 pre-adipocyte cell line, which demonstrated the role of Dlk1 inhibiting differentiation of 
pre-adipocytes, convincingly showed that Dlk1 directly and in a dose-dependent manner regulated 
the MEK/ERK pathway (Kim et al., 2007). This study also used mouse embryo fibroblasts 
(MEFs) derived from Dlk1-null mice, demonstrating that these mutant MEFs did not have 
phosphorylated ERK1/2, enhancing their ability to perform adipogenesis. Upon treatment with 
the recombinant secreted isoform of DLK1, ERK1/2 was phosphorylated and MEF adipogenesis 
was inhibited (Kim et al., 2007).  
The study which investigated the roles of secreted and membrane-bound DLK1 in NSC 
regulation in the adult SVZ (Section 1.4.4) assessed if any of this signaling occurs through Notch-
dependent pathways. The wild-type NSCs treated with DLK1 were examined for changes in 
downstream Notch targets, but no change was observed in Notch activity (Ferrón et al., 2011). 
This study did not examine all downstream Notch targets, so it is possible it is still a Notch 
mediated process. However, this evidence suggests that the recombinant DLK1, representative of 
the secreted form of DLK1, was not regulating NSC differentiation through the Notch signaling 
pathway. 
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1.8 Zebrafish as a model system for examining dlk1 and dlk2 function 
 
In order to examine the mechanisms by which dlk1 and dlk2 function, it is important to use an in 
vivo system with endogenous versions of the genes. As demonstrated throughout the Introduction, 
murine Dlk1 signals can potentially interact with signalling pathways in three different ways: 
autocrine, paracrine and endocrine. Therefore, in vitro systems, in which cells are isolated from 
their developmental context, might not fully replicate the more complex interactions with Dlk1. 
The zebrafish provides an ideal model system to examine dlk1 and dlk2 as it only contains a single 
copy of each of the two genes and dlk1 in zebrafish lacks the juxtamembrane cleavage site (Section 
1.2). This suggests that zebrafish dlk1 will be unable to encode the secreted isoforms of Dlk1 
protein, allowing for a model to examine the membrane-bound function of this protein without 
the complication of its secreted functions. In this section, the aspects of zebrafish development 
that will be further examined in this thesis are introduced.  
 
1.8.1 Zebrafish embryonic stages 
	
Embryonic stages of zebrafish that are described in this thesis are divided into the developmental 
stages outlined in a zebrafish staging series paper (Kimmel et al., 1995). The embryos examined in 
this report are post-gastrulation and are organised into the following categories depending on the 
hours post fertilisation (h.p.f.): 
Segmentation period (10-24 h.p.f.): This period is defined by the development of the 
somites. During this stage, primary organogenesis occurs. The embryo elongates and the 
tail bud is rapidly extended. 
Pharyngula period (24-48 h.p.f.): Organogenesis continues rapidly throughout the 
pharyngula period.  The body axis straightens, and pigment-containing cells form and limb 
(pectoral fin) formation is initiated. Circulation begins and the heart starts to beat at the 
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beginning of this period. This period is subdivided into primordium stages, known as 
“prim”. 
Hatching period (48-72 h.p.f.): Hatching of the zebrafish embryos is not always 
synchronised within a clutch and the stages are defined by hours of development, not by 
hatching time. This period marks the completion of rapid morphogenesis of many of the 
organ systems, with some notable exceptions such as the developing gut primordium. 
Cartilage begins to develop in the head. 
Early larval period (72 h.p.f. – 5 d.p.f.): By this stage, morphogenesis is complete and 
the larva continues to grow rapidly. The swim bladder inflates during this stage and the 
larva begins to seek food and increasingly responds to stimuli. 
 
1.8.2 Zebrafish neural stem cells in the embryo 
 
In the developing vertebrate brain, the generally accepted model is that before the onset of 
neurogenesis, the neural epithelium is populated by NSCs. The onset of neurogenesis results in 
NSCs becoming radial glial cells that will generate all the neurons and then glial cell populations 
(Paridaen and Huttner, 2014). This model is a basic generalisation and very little is known about 
the heterogeneity of this radial glial cell population and the way in which they generate neurons 
throughout development. As a transparent vertebrate embryo, zebrafish is potentially an ideal 
model to examine the development of these glial cell populations. In the zebrafish embryo, there 
are a population of glial fibrillary acidic protein (GFAP)-expressing radial glial cells (Johnson et al., 
2016). Through fate-mapping of this cell population, it was shown that they generated subsets of 
interneurons, secondary motorneurons and oligodendroglia cells. In addition, targeted ablation of 
these cells resulted in the loss of these later born neurons and glial cells, as well as a loss in 
maintenance of the NSC population (Johnson et al., 2016). 
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 These radial glial cell populations in the zebrafish embryo are regulated by Notch signalling 
(Appel et al., 2001). In the examination of a DeltaA (dlA) mutant zebrafish it was discovered that 
there is a reduction in the proliferative neural cell populations. Supporting the more recent findings 
of the ablation experiments, these dlA mutants had reduced later-born secondary motor neurons 
and glia (Appel et al., 2001; Johnson et al., 2016). The model suggested in this study is that the 
radial glial cells that are beginning the process of differentiation express elevated levels of Delta, 
which increases the Notch signalling in surrounding cells. This maintains the correct levels of self-
renewing radial glial cells through the lateral inhibition process often associated with Notch 
signalling (Appel et al., 2001). Losing Delta in the mutant causes cells to prematurely differentiate 
as early-born neurons, leading to the loss of the later-born neurons and maintenance of the radial 
glial cell population (Appel et al., 2001). 
 
1.8.3 Zebrafish adult neurogenic niches and their role in regeneration 
 
Unlike in the mammalian system, zebrafish have an amazing capacity for adult neurogenesis 
throughout the adult brain. Of particular interest is a population of radial glial cells situated on the 
periventricular zones of the adult telencephalon (März et al., 2010; Schmidt et al., 2013). These 
periventricular cells are categorised into three states (Chapouton et al., 2010; März et al., 2010; 
Schmidt et al., 2013):  
1. Quiescent radial glial cells: contain GFAP and high levels of Notch signalling. 
2. Dividing radial glial cells: contain GFAP but low levels of Notch signalling. 
3. Radial glial cells that express PCNA but no other radial glial markers. 
It has been demonstrated that these cells are regulated by the Notch signalling pathway; high levels 
of Notch activity maintain the radial glial cells as a quiescent population (state 1) and the reduction 
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of Notch signalling, upon injury, results in the radial glial cells actively dividing and repopulating 
the damaged area (Chapouton et al., 2010; Kroehne et al., 2011). 
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1.9 Aims 
	
The studies performed to date on Dlk1 in the mouse raise a series of questions regarding the 
relationship between the membrane-bound and secreted isoforms of DLK1 protein, the occurring 
receptor-ligand interactions, and the different isoforms’ signaling pathways. Deciphering these 
questions in vivo in mouse is difficult, as it is challenging to modulate the different isoforms 
separately as they are expressed from the same gene locus. In addition, Dlk1 has clearly developed 
many roles within the mammalian system that may complicate understanding its mechanistic 
function in the Dlk1-null mouse. In particular, the secreted DLK1 that behaves as a circulating 
hormone makes it difficult to identify all of the sites of function. It also makes in vitro studies 
challenging to interpret because they are possibly taken out of the endogenous context of DLK1 
protein. Therefore, the ultimate aim of this project is to produce an in vivo model to elucidate the 
mechanism, and potential ancestral mechanisms, by which dlk1 and dlk2 genes function. 
 
Aim 1: The first aim of this project was to examine the expression of dlk1 and dlk2 in zebrafish 
development. By doing so, the aim was to understand the function that dlk1 and dlk2 play in 
zebrafish development, but most importantly, to identify model systems, such as specific organs 
or developmental events, in which to examine the mechanism by which these genes function.  
Aim 2: To understand the effect of modulating dlk1 and dlk2 expression in vivo. These genes are 
known to be highly dosage sensitive in the mouse. Therefore, gene function was investigated using 
available knockdown techniques to reduce the protein levels and examine their in vivo function. 
Aim 3: To produce and characterise dlk1 and dlk2 mutant zebrafish to be used as a model system 
for elucidating their mechanistic function. 
Aim 4:  To examine the dlk2 mutant produced as part of the zebrafish mutation project with 
particular focus on the model systems identified in aim 1.  The ultimate aim was to use this system 
to understand the mechanism by which dlk2 functions in zebrafish. 
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2. Materials and Methods 
 
2.1 Fish maintenance and handling 
 
Fish were maintained under standard conditions, as previously described (Westerfield, 1995), on a 
14-hour light and 10-hour dark cycle. Embryos, obtained from natural spawning, were reared in 
embryo medium (E3M) (5 mM NaCl, 0.17 mM KCl, 0.33 mMCaCl2, 0.33 mM Mg2SO4, 5 mM 
HEPES), allowed to develop at either 25oC or 28oC, and were staged according to established 
criteria (Kimmel et al., 1995) before fixing in PFA. 
 
2.2 Fin clipping, DNA extraction and genotyping 
 
Adult zebrafish were anaesthetised by immersion in 150 mg/L tricaine, briefly removed from the 
media. A small piece of tail fin tissue was removed and placed in a microfuge tube and stored at  
20oC prior to DNA extraction.  25 uL of lysis buffer (25 mM NaOH with 0.2 mM EDTA) was  
added to tail fins or whole embryos in individual tubes and incubated at 95oC for 30 mins.  25 uL 
neutralisation buffer (40mM Tris-HCl) was added, samples were mixed by vortexing and then 
either used immediately or stored at -20 oC.  Genotyping was performed using a custom genotyping 
assay (KASPAR genotyping assay, LGC genomics) using fluorescent primers designed to the wild-
type and mutated DNA sequence. (The KASP assay primers were designed to the following 
sequence to detect mutation: 
TAAACATTGTRGATTTTGAYTTCATGTTAAAAGACMGTGACTCTTTCCGC[A/T]GA
TGTTTACGTGTGCTCCAGACAGCAGCCGTGTCATAACGGGRCCACTTG) Genotyping 
assays were run on a Roche LightCycler II 480 and analysed using the endpoint genotyping 
software.   
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2.2 Zebrafish Microinjections 
 
Zebrafish microinjections were conducted on one-cell stage embryos using pulled glass capillaries 
(Harvard Apparatus GC100F-10), pulled using a Sutter Instrument Company Model P-2000 
needle puller.  One-cell stage embryos were lined up on a glass slide and injected through the yolk 
into the cell using an Intracel Picospritzer® III running on 70 psi.  Injection volume was calibrated 
by measuring the size of injection volume in mineral oil using a Zeiss Stemi 2000 microscope with 
W-PI 10x/23 eyepiece reticule.  Injections were controlled in the following ways.  First, for every 
MO injection, a control injection (Danieau’s solution) and a mismatch MO injection at the same 
volume/concentration were performed in the same clutch.  This was to ensure that all injected 
embryos would be developmentally matched, and so that controls could be compared with MO 
injected fish.  Second, for every injection a portion of embryos was left uninjected and examined 
to ensure that embryos were of high quality.  If uninjected embryos had high percentage of defects, 
injected fish were discarded and not analysed further. Morpholino oligonucleotides (MO) were 
generated by GeneTools LLC Morpholinos (Dlk2 MO: 5-
GCAGCAGAACGACAGCGAGTTTCAT-3, Mismatch control: 5-
GCACCACAAGGACAGCCACTTTCAT-3).   Following injections, embryos were stored at 28.5 
oC in the dark in a Binder KB53 heating/cooling incubator until 7 hours post-fertilization (h.p.f., 
hours post-fertilization at 28.5oC) before they were cleared of dead and unfertilized eggs, and then 
returned to incubate at 28.5oC in the dark.   
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2.3 Zebrafish Processing 
 
2.3.1 Embryo Fixation 
 
Embryos were staged by morphology and at the desired stage of development, anesthetized with 
an excess of Ethyl 3-aminobenzoate methanesulfonic acid (Tricaine) and fixed while rocking in 
either 4% PFA in PBS or Dent’s fixative (20% DMSO 80% Methanol).  Fish were fixed overnight 
at 4oC, after which PFA-fixed fish were rinsed out three times in PBS for 10 minutes and two 
times in methanol for 10 minutes.  Fish fixed in Dent’s fixative were rinsed in methanol twice for 
10 minutes each.  All fixed fish were stored in methanol at -20oC for long term storage.   
 
2.3.2 Cryostat Sectioning 
 
Embryos previously fixed in 4% PFA at desired developmental stages were rehydrated from 
methanol in a series of five minute rinses to PBS (50% PBS/50% methanol, 75% PBS/25% 
methanol, 90% PBS/10% methanol, 100% PBS).  Rehydrated embryos and whole mount 
immunostained embryos were then incubated in 30% sucrose in PBS at 4oC overnight, and then 
mounted in Tissue-Tek O.C.T. embedding medium and frozen at -30oC.  Embryos were then 
sectioned at 10 nm using a Bright 5030 Cryostat and collected on Thermo Menzel-Gläser 
Superfrost Plus slides, which were dried at room temperature for 10 minutes before storage at -
20oC.  Embryos were mounted to obtain coronal sections of the zebrafish brain.  Only sections 
containing one or both lenses of the eyes were used for analysis to ensure that sections between 
different fish were anatomically matched.   
 
2.3.3 mRNA Harvesting 
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For each mRNA sample, one hundred zebrafish at the appropriate developmental stage were 
dechorionated, transferred to 1.5 mL Eppendorf tubes on ice and excess liquid was removed.  
Embryos were then mixed with 350 µL Buffer RLT (Qiagen RNEasy kit) homogenized using 1.0 
mm glass beads in a Qiagen TissueLyser LT at 50 Hz for 40 seconds.  Homogenized samples were 
then snap frozen to -80oC, thawed, and then processed following standard protocols with a Qiagen 
RNEasy kit, summarized as follows:  
 Homogenized samples were centrifuged through a gDNA Eliminator Column (10,000 
rpm, 30 seconds), after which flow-through was saved and mixed with 1 volume of 70% Ethanol.  
The sample was then mixed, transferred to an RNEasy Column, and spun for 15 seconds at 10,000 
rpm.  The column was then rinsed with 700 µL RWI solution, two rinses of 500 µL RPE solution, 
uand then placed in a sterile RNAse free tube.  RNA was then eluted in 50 µL of RNAse free 
double distilled H2O (ddH2O).   
 
2.3.4 cDNA Generation 
 
After purification, RNA samples were evaluated by agarose gel electrophoresis (0.8% gel, 0.1 µL 
SafeView Nucleic Acid Stain, run at 100V for 10 minutes) and spectroscopy using a Nanodrop 
ND1000 spectrophotometer, then stored at -80 oC.  cDNA was generated from RNA samples 
using an Applied Biosciences High Capacity Reverse Transcription Kit and following standard 
protocol.  In brief, a complete reverse transcription master mix (composed of reverse transcription 
buffer, dNTP mix, reverse transcriptase, RNAse inhibitor, and random primers) was mixed with 
an equal volume of prepared zebrafish mRNA, and run through the following temperature steps 
in a Peqlab Peqstar 96 Universal Gradient Thermal Cycler: 25oC for 10 minutes, 37oC for 120 
minutes, 85oC for 5 minutes.  cDNA was then stored at -80oC.   
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2.4 In situ hybridisation 
 
ISH was performed as previously described (Thisse and Thisse, 2008). PCR products were cloned 
into a TOPO PCR II vector and then in vitro transcription was performed using Roche DIG RNA 
Labeling Kit (SP6/T7) to produce dig-labeled anti-sense and sense RNA probes. (Dlk1 1st probe: 
TGTCCGGCTGGGTTCACTGG, ACCAGCTGCCTGTACCTCAC; 2nd probe: 
CCGCTATCGTCTTCTTCCAG, CACAGTTTGGTTCTCCAGCA. Dlk2 1st probe: 
AAGAAACGTCTCCGACTCCA, GAAGCCTTCAGGACACAAGC; 2nd probe: 
AATGCACATGTTCTGGGAAC, AACCTAAGCATCTCATCACA) ISH embryos then had 
their yolk sac cleared through glycerol washes before whole mount imaging.  
 
2.5 Whole Mount Immunostaining 
 
Embryos previously fixed in either 4% PFA or Dent’s Fixative at desired developmental stages 
were rehydrated from methanol storage at -20oC in rinses to PBS (50% PBS/50% methanol, 75% 
PBS/25% methanol, 90% PBS/10% methanol, 100% PBS).  Rehydrated embryos were then 
blocked in 10% Goat Serum PBS with 0.1% Tween-20 for 1 hour at room temperature, and then 
incubated in primary antibody in 10% Goat Serum PBS with 0.1% Tween-20 at 4oC overnight.  
After incubation in primary antibody, embryos were washed out four times in PBS with 0.1% 
Tween for ten minutes each, and then incubated in appropriate fluorescent secondary for two 
hours at room temperature.  After incubation in secondary antibody, embryos were again washed 
four times in PBS with 0.1% Tween for ten minutes each and stored in PBS at 4oC.  The following 
primary antibodies were used: anti-HuC (1:200, Santa Cruz), anti-GFAP (1:4, ZIRC zrf-1), and 
anti-PHH3 (1:200, Millipore).  The following secondary antibodies were used: goat anti-mouse 
conjugated to Alexa Fluor 488 (1:1000, Invitrogen), goat anti-rabbit conjugated to Alexa Fluor 488 
(1:500, Invitrogen).   
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2.6 BrdU analysis 
 
BrdU labeling was performed as previously described (Westerfield et al., 2009). Embryos were 
injected with 0.025ng (in 0.52 µl) of dlk2 MO or mismatch at the 1 cell stage. At 24 h.p.f. and 48 
h.p.f., BrdU labeling was performed on the MO, the mismatch and uninjected siblings. The BrdU 
was allowed to incorporate for 5, 10 or 15 minutes. As there was little difference between these 
times, a 5 minute incorporation was used for replications. 
 
2.7 Microscopy and image processing 
 
2.7.1 Brightfield imaging  
 
All brightfield images were taken on Axio zoom V1.6 microscope with ZEN 2012 software. Whole 
mount embryos were embedded in either 3% methyl cellulose in E3 medium or 2% low melting 
point agarose.  
 
2.7.2 Time-lapse microscopy  
 
In order to produce time-lapse films of the developing embryos, they were embedded in 2% 
agarose and 0.016% tricaine (3-amino benzoic acid ethylester) in E3 medium. The embryos were 
then imaged using an Axio zoom V1.6 microscope with ZEN 2012 software. The embryos were 
maintained at 28oC using a heated stage. 
 
2.7.3 Confocal imaging and processing 
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Confocal images were captured Nikon Eclipse C1si. Embryos were embedded in 2% low melting 
point agarose onto a slide cover. The slide covers were suspended on a slide holder that allowed 
them to be imaged on the upright confocal. Wild type embryos were always imaged first and the 
settings were reused for the treatment groups. Z-stack images were processed in image J, maximum 
intensity projects were made with no further processing.  
 
2.8 CRISPR-cas9 Guide RNA   
 
The guide RNA sequences were cloned into pDR274. (Target sequences. Dlk1: 
GGCGAGTGTATCTGTGAGTCCGG, GGCGGGCGATGCGTCCGGCGTGG. Dlk2: 
GGCAGGTGTGATCCGGGATGGGG, GGCAGTGCTCCTGCATGGACGGG) The guide 
RNA and the Cas-9 RNA were in vito transcribed using the mMessage machine Ultra T7 kit 
(Invitrogen). The 25pg of guide RNA and 300pg of Cas9 RNA were injected into the one-cell 
embryo.  
 
 
2.9 Behavioural Tracking 
 
Tracking equipment was from Zanticks LTD. A 24 well plate was placed in a dark Perspex box 
and monitored by a camera. Proprietary software was used to track individual fish movements 
over time. Single larval fish were placed in each well and allowed to acclimatise for at least 1 hour 
before tracking began.  
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3.  Analysis of the expression patterns of 
dlk1 and dlk2 during early development and 
in the adult brain of zebrafish. 
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3.1 Introduction 
 
To understand the expression dynamics of dlk1 and dlk2 in the developing zebrafish, a spatio-
temporal analysis was performed using mRNA in situ hybridisation. To date, there is no published 
data on the expression of these genes in zebrafish; however, there is detailed analysis of murine 
Dlk1 during mouse development (da Rocha et al., 2007; Yevtodiyenko and Schmidt, 2006). In 
addition, as described in section 1.4.4., murine Dlk1 plays an essential role in the regulation of 
neural stem cells within the subventricular zone in the adult mouse (Ferrón et al., 2011). Zebrafish 
maintains multiple neurogenic niches in the adult brain, which, if regulated by dlk1 or dlk2, could 
provide an ideal model system to examine the mechanism by which these genes regulate stem cell 
niches (Chapouton et al., 2011). Therefore, in addition to describing the developmental expression 
pattern of dlk1 and dlk2, an analysis of the expression of these two genes in the adult brain was 
performed. mRNA in situ hybridisation (ISH) and immunohistochemistry (IHC) techniques were 
used to address the following aims:  
1. To compare and contrast the expression of murine Dlk1 with zebrafish dlk1 and dlk2 
to explore the evolutionary conservation of the developmental expression of these 
genes. 
2. To understand the expression of dlk2 in the context of notch signalling pathways. 
3. To identify optimum regions of expression for examination within dlk2 knock-down 
and knock-out approaches. 
 
3.2 Results and discussion  
	
3.2.1 dlk1 is ubiquitously expressed during the segmentation phase of zebrafish embryonic 
development. 
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Using in situ hybridisation, the expression pattern of dlk1 was investigated from the post-
gastrulation bud phase (10 h.p.f.). This marks the beginning of the segmentation phase of 
embryogenesis, which includes the completion of somitogenesis and neurogenesis (Kimmel et al., 
1995). This phase ends at around 24 h.p.f., coinciding with the completion of somitogenesis. Dlk1 
is ubiquitously expressed in the 10 h.p.f. embryo body (Fig. 3.1A and B). Figure 3.1A shows a 
lateral view of the embryo and Figure 3.1B shows a dorsal view to demonstrate clear expression 
throughout the developing neural epithelium. This ubiquitous expression is maintained 
throughout the segmentation phase, and continues to be expressed throughout the 18 somite (~18 
h.p.f.) zebrafish embryo (Fig. 3.1C and D).  
 The ubiquitous expression of dlk1 in the early zebrafish shares some similarities with the 
expression of Dlk1 in early stages of murine development. At E10, murine Dlk1 is broadly 
expressed in the mouse embryo before becoming increasingly localised to specific locations later 
in development (da Rocha et al., 2007). In mouse, Dlk1 is expressed throughout undifferentiated 
mesenchyme. This tissue is comparable to the pre-somitic mesoderm in zebrafish, in which dlk1 
is expressed throughout the segmentation period (Fig. 3.1). Murine Dlk1 is also expressed in the 
developing retina, and shows expression in the optic primordium and optic vesicle of the bud-
stage and 18–somite-stage zebrafish, respectively. However, murine Dlk1 is only expressed in 
specific ectodermal tissues at this stage in development, such as the optic chiasm, Rathke’s pouch 
and the developing pituitary gland. Zebrafish dlk1 is expressed throughout the ectodermal tissues, 
as well as all mesodermal tissue. 
 
3.2.2 dlk1 expression becomes increasingly restricted to anterior domains by the 
pharyngula stage of embryonic development. 
	
	
The pharyngula stage of zebrafish development marks the continuation of organogenesis, with the 
formation of many of the major organs. Dlk1 maintains a broad domain of expression at this stage 
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of zebrafish embryonic development. At 25 h.p.f. zebrafish have strong dlk1 expression 
throughout the brain, including the forming telencephalon, optic tectum, cerebellum, 
rhombencephalon and developing retina (Fig. 3.2A and B). These 25 h.p.f. embryos also show 
lower expression of dlk1 in the developing trunk relative to the anterior neuronal regions. 
However, expression is maintained at these low levels in these mesodermal tissues throughout the 
pharyngeal stage, from 25 h.pf to 42 h.pf. (Fig. 3.2 A-F). At the end of the pharyngula stage 
development (42 h.p.f.), dlk1 expression can be seen in some endodermal tissues such as the liver 
and forming gut primordium (Fig. 3.2E).  
 The murine E12.5 embryo maintains a much higher expression of Dlk1 in the mesodermal 
tissues relative to the ectoderm. Unlike the expression pattern observed in zebrafish, murine Dlk1 
is never expressed in such a broad manner in ectodermal tissue, being constrained largely to the 
developing pituitary gland, hypothalamus and optic recess (da Rocha et al., 2007). Murine Dlk1 
has very strong expression in endodermal tissues at E12.5, particularly in the liver, which is also 
observed in the developing zebrafish. 
 
3.2.3 dlk1 expression is constrained to neuronal regions during the hatching stage of 
embryonic development. 
	
 
The hatching stage is a period of rapid morphogenesis and occurs from 48 h.p.f. to 72 h.p.f. Most 
of the major organ systems complete rapid morphogenesis by the end of this phase. In the 48 
h.p.f. embryo, dlk1 expression is constrained to the brain (Fig. 3.3A and B). All previous 
mesodermal expression of dlk1 has ceased by the hatching stage. The brain has a broad domain of 
dlk1 expression throughout from 48 h.p.f. and is maintained in this fashion until 60 h.p.f. (Fig. 3.3 
C-F). The 48 h.p.f. zebrafish maintains strong expression in the developing liver (Section ISH 
performed by Sophie Miller). 
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 In contrast, the E16.5 mouse embryo has very low levels of Dlk1 in neuronal tissues, 
becoming constrained to highly specific locations. Additionally, murine Dlk1 maintains its 
mesodermal expression to a much higher degree than zebrafish. At this stage, the zebrafish embryo 
maintains dlk1 liver expression, much like the mouse.   
 
3.2.4 dlk1 is expressed in specific neuronal locations in larval zebrafish. 
 
At 72 h.p.f., the zebrafish is a free swimming larvae, able to respond to basic stimuli such as touch 
and vibration (Kimmel et al., 1995). By 72 h.p.f., dlk1 has become constrained to specific regions 
of neuronal tissues (Fig. 3.4A). The larval zebrafish have high expression in specific regions of the 
optic tectum and medulla oblongata. However, dlk1 is still expressed throughout the larval brain 
as well (Fig. 3.4A). This expression pattern is maintained up until 5 d.p.f. (Fig. 3.4 C-D).  
 Postnatal mice have very limited expression of Dlk1, and its expression becomes 
increasingly restricted in the lead up to birth. In the postnatal mouse brain, Dlk1 is restricted to 
the sub ventricular zone, in contrast to the zebrafish larvae which express dlk1 throughout the 
brain. 
 
3.2.5 dlk1 is expressed in radial glial cells in the adult telencephalon. 
 
Since murine Dlk1 is expressed in the neural stem cells of the subventricular zone, a comparative 
investigation was performed in the adult zebrafish brain using ISH on wax sections.  Expression 
was observed in the peripheral cell layer of the adult telencephalon. The location of the dlk1 
expression closely matched that of the described radial glial cells, shown to be responsible for 
regeneration upon injury of the telencephalon (Kroehne et al., 2011). The zebrafish radial glial cells 
in the telencephalon fall into three categories: Type I are quiescent cells waiting for a stimulus to 
become activated, and Type II are a population of dividing cells that self-renew and differentiate 
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into Type III cells, which are a transit amplifying cell population. Type I is identified by the co-
expression of GFAP and notch signalling, Type II by GFAP and PCNA, and Type III by the 
expression of PCNA only (Chapouton et al., 2010; März et al., 2010). In order to confirm that the 
expression of dlk1 was in these particular cells, dlk1 ISH was performed in a Her4:GFP transgenic 
zebrafish, followed by IHC with GFAP and PCNA antibodies. Using these radial glial cell markers, 
it can be seen that dlk1 is expressed in the radial glial cell population.  
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Figure 3.4 | dlk1 is expressed in specific neuronal locations in larval zebrafish 
A, shows a lateral view of dlk1 ISH at the protruding mouth stage (72 h.p.f.). B, shows a dorsal 
view of dlk1 ISH at the protruding mouth stage (72 h.p.f.). Expression of dlk1 is seen only in the 
brain region and is absent in the trunk.  C and D, Show two different representative lateral view 
images of dlk1 ISH at the 4-day larval stage. Dlk1 expression is seen in the brain and also the 
branchial arches. E, shows a lateral view of dlk1 ISH at the 5 day larval stage. F, shows a dorsal 
view of dlk1 ISH at the 5-day larval stage. G, is a schematic of a dorsal view of the larval 
zebrafish with a representation of dlk1 ISH signal. Dlk1 expression persists in the brain and 
branchial arches but is absent from all trunk tissues. Telencephalon (T), optic tectum (OT) 
cerebellum (C) hindbrain (HB) branchial arches (BA) brain stem (BS). Scale bar, 0.5mm 
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Figure 3.5 | dlk1 is expressed in Type I and Type II radial glial cells in the adult 
telencephalon. 
A., schematic representation of a transverse section through the adult zebrafish telencephalon 
with boxes demonstrating where the rest of the images in the figure are situated. B., 
Representative image of dlk2 ISH followed by IHC for PCNA and GFAP, in the context of a 
her4:GFP transgenic fish (described in materials and methods, section 2.xx). The IHC was 
performed on the same section with a photo-bleaching step in between each IHC that required 
the use of the same secondary antibody fluorophore (materials and methods, section 2.xx). C., 
Demonstrates the presence of dlk1 in type I radial glial cells, where both her4 and GFAP are 
present. D., Demonstrates the presence of dlk1 in type II radial glial cells, where GFAP is 
present but her4 is not.   
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3.2.6 Unlike dlk1, dlk2 becomes localised to the anterior of the zebrafish embryo during 
the segmentation phase  
 
ISH of dlk2 at the segmentation phase of zebrafish development shows that, like dlk1, dlk2 is 
ubiquitously expressed at the bud stage of embryonic development (Fig. 3.6A and B). However, 
by 18 somites, dlk2 expression is beginning to become localised to the anterior portion of the 
zebrafish embryo at an earlier stage than dlk1 (Fig 3.6 C and D). There is still expression in the tail 
bud and pre-somatic mesoderm, but this is reduced in comparison to the anterior of the embryo 
and in contrast to dlk1 expression (Fig. 3.1C and D). The somitic mesoderm retains dlk2 expression 
at this stage.    
 
3.2.7 dlk2 expression becomes localised to anterior neuronal structures by the pharyngula 
stage of embryonic development. 
 
By prim-6, dlk2 expression is restricted to the developing brain, earlier then dlk1 (Fig. 3.7A and 
B). However, by prim-16, dlk2 and dlk1 have very similar and overlapping expression patterns. 
(Fig. 3.7C and D).  This similarity and overlapping of expression is maintained through to the end 
of the hatching period (Fig. 3.8).  
 
3.2.8 dlk2 is expressed in specific neuronal locations in larval zebrafish that are distinct 
from that of dlk1. 
  
Dlk2 ISH was performed on larval zebrafish from 72 h.p.f. to 5 d.p.f. (Fig. 3.9). From a lateral 
view of the zebrafish larvae, dlk1 and dlk2 appear to have overlapping expression patterns (Fig. 
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3.9A and B). Both are expressed in the larval zebrafish brain. However, a dorsal view clearly 
indicates distinct domains of expression (Fig. 3.9D). Dlk2 is expressed in the telencephalon 
midline, the proliferative zone at the extremity of the optic tectum, and the vagal lobe.  
 
3.2.10 DLK2 protein mostly co-localises with dlk2 expression and is present in domains 
expressing Notch signalling during zebrafish development  
 
DLK2 antibodies were produced as a result of ongoing collaborations with Abcam. Two DLK2 
antibodies were produced and characterised in the laboratory, one against a mouse epitope and 
another against the full length human recombinant protein. Both are polyclonal antibodies. 
Neither antibody showed specific staining in western blot analysis (not shown), but specific 
labelling was observed with the polyclonal human DLK2 antibody. Furthermore, this staining was 
absent in homozygous dlk2 mutant zebrafish (described in section 3.1). Whole mount IHC was 
performed in the context of a Notch transgenic reporter. At segmentation, pharyngula and larvae 
stages showed DLK2 localisation correlates closely with dlk2 in situ expression patterns (Fig. 3.10). 
This suggests that the antibody is not detecting DLK2 protein within the same tissues/cells that 
express the dlk2 mRNA.  Therefore, it can be interpreted that either the DLK2 protein it is not 
secreted in zebrafish or the secreted portion of the protein is not detected by the antibody used.   
 
3.2.11 Dlk2 protein is expressed in cell populations adjacent to those expressing Notch 
activation markers in the larval brain 
 
To investigate the specific cell populations expressing DLK2 protein, sections of Notch-reporter 
larval zebrafish, had DLK2 IHC performed on them. The whole mount DLK2 IHC demonstrates 
that active Notch signalling is occurring within the same domains in which DLK2 is present (Fig. 
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3.10). However, at high magnification, one can observe that there is no co-localisation between 
the cells expressing the Notch reporter and those expressing DLK2 at this stage (Fig. 3.11). 
Instead, DLK2 is present in cells that are adjacent to the cells with active Notch signalling. This 
suggests that if DLK2 is regulating Notch signalling, it is via trans-regulation not cis-regulation, 
hinting at possible mechanisms for the functioning of this protein. 
 
3.2.11 Dlk2 protein is present in the radial glial cells in the telencephalon 
 
Dlk2 expression was examined in the adult telencephalon using ISH. Unlike dlk1, dlk2 never 
produced any in situ signal in the adult telencephalon. By performing Dlk2 IHC on sections of wild 
type adult telencephalon, signal was found to co-localise with GFAP IHC (Fig 3.12). This 
demonstrates that Dlk2 protein is localised in the radial glial cell population. 
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Figure 3.9 | dlk2 is expressed in specific regions of the larval zebrafish brain. 
A, shows a lateral view of dlk2 ISH at the protruding mouth stage (72 h.p.f.). B, shows a dorsal 
view of dlk2 ISH at the protruding mouth stage (72 h.p.f.). Expression of dlk2 is seen only in the 
brain region and is absent in the trunk. C and D, Show two different representative lateral view 
images of dlk2 ISH at the 4 day larval stage. In addition to the brain expression, dlk2 is expressed 
in the brachial arches.  E, shows a lateral view of dlk2 ISH at the 5 day larval stage. F, shows a 
dorsal view of dlk2 ISH at the 5 day larval stage. At this stage, dlk2 is highly expressed in the 
brain, with very specific localisation in the midline of the telecehpalon, and the peripheral zones 
of the optic tectum and cerebellum. G, is a schematic of a dorsal view of the larval zebrafish with 
a representation of dlk2 ISH signal, showing the specific regions of dlk2 expression visable from 
the dorsal view of a larval zebrafish brain.  Telencephalon (T), Optic Tectum (OT) Cerebellum 
(C) Hindbrain (HB) Branchial Arches (BA) Brain Stem (BS). Scale bars, 0.5mm. 
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Figure 3.10 | DLK2 is localised to the same regions as the dlk2 in situ. 
A., Shows DLK2 IHC in the context of the notch reporter transgenic zebrafish at the 18 h.p.f. 
stage of embryonic development. B., Shows DLK2 IHC performed in the notch reporter 
transgenic zebrafish at the 24 h.p.f. stage of embryonic development. C., Shows DLK2 IHC 
performed in the notch reporter transgenic zebrafish at the 5 d.p.f. larval stage. Scale bars, 0.5 
mm 
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3.3 Conclusion  
	
	
The investigations described in this chapter have shown that both dlk1 and dlk2 are expressed 
during zebrafish embryonic development. Zebrafish dlk1 and dlk2 share very similar expression 
patterns, with subtle differences between the two. Namely, dlk2 expression becomes restricted to 
the anterior of the embryo earlier in development than dlk1 (Fig. 3.13). Furthermore, when dlk1 
and dlk2 become highly localised in the zebrafish larval brain, their expression is in distinct regions 
from one another. This study identified two interesting areas in which to further examine the 
function of these genes: 1) The neural regions of the larval brain and 2) the radial glial cells in the 
adult telencephalon.  
Dlk1 and dlk2 have very different expression domains when compare to Dlk1 in mouse. However, 
there are similarities in their expression when compared to Dlk2 expression in mouse embryos 
(Fig 3.14; data provided by Alex Ashcroft). Murine Dlk2 has much broader expression than Dlk1, 
and it is also highly expressed in neuronal regions. Taken together, this suggests that neuronal 
expression of dlk1 and dlk2 may well be the ancestral state of the gene and the differences observed 
in Dlk1 expression in mouse may be a result of the evolution of mammalian-specific functions.  
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Figure 3.13 | Summary of dlk1 and dlk2 in situ throughout zebrafish embryonic 
development. 
This figure shows a full comparison of dlk1 and dlk2 in situ through development for the sack of 
ease of comparison between the two. The figure also shows some controls: Sense probe controls 
that were used to demonstrate the specific nature of the anti-sense probe signal, and shh probes 
that were used in order to demonstrate the effectiveness of the in situ method. This probe was 
selected because of its well characterised and discrete domain of expression and to demonstrate 
probe penetration due to the location of the signal in the centre of the larval zebrafish.  
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4. Approaches to knock-down and knock-
out dlk1 and dlk2 in zebrafish 
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4.1 Introduction 
 
The aim of this thesis is to understand the mechanisms by which dlk1 and dlk2 function. The first 
approach to examine this was to use available knock-down approaches. Murine Dlk1 has been 
demonstrated to be highly dosage dependent (Charalambous et al., 2012). This supports the 
approach of examining the effects of dlk1 and dlk2 knock-down. However, murine Dlk1 behaves 
in an autocrine, paracrine and endocrine manner  (Cleaton et al., 2016; Ferrón et al., 2011; Sul, 
2009). When multiple different forms of action are operating simultaneously, an extra level of 
complexity is added when it comes to interpreting knock-down phenotypes and elucidating 
mechanistic function.  Therefore, producing a genetic mutant was a key aim of this project. The 
targeted genomic knockout technology CRISPR-Cas9 was described during the course of this 
project (Le Cong et al., 2013). Experiments were performed to optimize this technology and to 
produce dlk1 and dlk2 mutants using this system, but the generation of dlk1 and dlk2 targeted 
mutations was not successful.  
 Morpholino oligonucleotides (MOs) are anti-sense oligonucleotides that target the gene of 
interest and are specifically designed to the ATG start site to block translation, or to intron/exon 
splice boundaries to block the correct splicing of the target RNA (SUMMERTON and WELLER, 
1997). They have been frequently used in zebrafish as a mechanism for targeted gene knock-down. 
However, analysis of morpholino knock-down phenotypes that have been previously described 
show very little correlation to phenotypes that result from genomic mutations of the same gene 
(Kok et al., 2015). Another study determined that the differences between the morpholino knock-
down and a genomic mutation phenotype can be due to genetic compensation mechanisms (Rossi 
et al., 2015). Ultimately, MOs are a useful knock-down approach, but it is clear that there are 
numerous off-target effects (Rossi et al., 2015). In order to mitigate off-target effects, a mismatch 
MO is used, demonstrating that the MO with a 4bp mismatch from the target has no phenotype, 
which provides some evidence against off-target effects (PARTRIDGE et al., 2009). However, it 
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is still not possible to mitigate against all off-target effects and this will always cause difficulty in 
interpretation of MO results. 
This chapter describes the results of MO studies targeting dlk1 and dlk2. However, mismatch 
controls designed as variants on the dlk1 MOs were always found to produce abnormal 
phenotypes. Mismatch controls for dlk2 MO injections yielded clean results, free from any 
abnormalities, and so only results of dlk2 knock-down are presented here.  
 
 
4.2 Results 
	
	
4.2.1 MO knockdown of dlk2 leads to developmental abnormalities. 
 
To investigate the role of dlk1 and dlk2 in early zebrafish development, translation-blocking MOs 
were used to transiently knockdown expression of dlk1 and dlk2. In the initial analysis of the MOs, 
both a 25bp anti-sense oligonucleotide targeting the translational start site and a 5bp mismatch 
(MM) control were used to determine the specificity of targeting MOs. Several MO/MM pairs 
were tested for dlk1, but as both the MO and the MM displayed the same phenotypes in all cases, 
these were not analysed further. A concentration analysis was performed on the dlk2 MO and MM 
pair. This analysis was performed to determine the concentration at which no phenotype was seen 
in the MM control, as well as to observe the MO knockdown phenotype at different doses. 
Ultimately, the MO analysis revealed minor developmental abnormalities to the surface of the 
neuroepithelium that were identifiable on a dissecting microscope, which could be categorized as 
either having or not having “head defects” as compared to controls (Fig 4.1A and B). Injection of 
0.05ng of MM showed very little developmental abnormalities, hence the rest of the experiments 
in this report were performed at the 0.05 ng concentration (Fig. 4.1B). To understand how the 
dlk2 knockdown leads to the observed phenotypes, the earliest time point at which the defects 
manifest was determined. Another phenotype observed after MO injection was the reduction in 
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size of the developing zebrafish embryo. BrdU labelling was performed at 24 h.p.f. and 48 h.p.f. 
on the MO, MM and uninjected embryos. BrdU analysis revealed that proliferation rates are 
equivalent at 24 h.p.f.; however, the dlk2 MO-injected embryos have massively reduced levels of 
proliferation at 48 h.p.f. (Fig. 4.1C).  
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4.2.2 Knockdown of dlk2 leads to the reduction of a specific domain of Notch pathway 
activation. 
 
To understand the effect of dlk2 knockdown on the Notch signaling pathway, transgenic zebrafish 
containing eGFP driven downstream of a series of RBP-JK enhancer sites were used (Parsons et 
al., 2009). When the Notch signaling pathway is activated, the Notch intracellular domain (NICD) 
binds to its co-factors, including RBP-JK, and drives the expression of the eGFP. This provides a 
live readout of Notch activity. Analysis of embryos from the onset of expression of the Notch 
activation marker at 14 h.p.f. until 24 h.p.f. revealed no difference in Notch signaling activity in 
the dlk2 MO-injected fish compared to the MM control. Between 24 h.p.f. and 48 h.p.f., however, 
there was a large amount of Notch activity in the hindbrain of the non-injected and MM-injected 
developing embryo, and this activity was markedly reduced in the dlk2 MO injected embryos (Fig. 
4.2). Figure 4.2 shows representative stills from a time lapse of development  between 34 
h.p.f. and 46 h.p.f. of development. In uninjected controls, there is a strong domain of Notch 
activation in the hindbrain during this period of development (Fig 4.2), which does not happen in 
the MO injected embryos (Fig 4.2). During this time, Notch is also active in the olfactory bulb, 
heart, trunk and tail. Notch activity in these areas was largely unperturbed in the dlk2 MO injected 
fish, with defects restricted specifically to the hindbrain, which is an observation in keeping with 
the gross morphological defects observed (Fig. 4.2). This suggests that dlk2 is involved in a very 
specific domain of Notch signaling during early zebrafish development. 
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4.2.3 Dlk2 MO knockdown leads to a reduction in Dlk2 protein. 
 
 
Zebrafish embryos were injected with 0.025ng of the dlk2 MM control and MO and fixed at 24 
h.p.f. IHC was performed using the Dlk2 antibody. In the MM control embryo, the Dlk2 antibody 
produced normal signal from the Dlk2 IHC (Fig. 4.3A). In the dlk2 MO injected zebrafish, there 
was a reduced Dlk2 signal, demonstrating that dlk2 MO injection leads to a reduction in Dlk2 
protein levels.    
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4.2.4 Using CRISPR-Cas9 to generate dlk1 and dlk2 mutants. 
 
 
CRISPR-Cas9 mediated genomic editing was performed in zebrafish by co-injecting Cas9 RNA 
with the RNA of the guide for the target sequence. Injection conditions, guide RNA and Cas9 
concentrations were optimised using guide RNAs designed to the albino locus (guide RNA 
plasmid kindly provided by Steve Harvey, Sanger Centre).  Guide RNAs to zebrafish dlk1 and dlk2 
were designed to Zv9 (genome release 9).  Injections were performed at the previously optimised 
concentrations into eggs from wild type zebrafish lines and the Notch-reporter line. Several 
hundred embryos were grown from three separate rounds of guide RNA injection. These fish were 
grown on the system while a genotyping technique was developed. If the mutation occurred, the 
injected fish would be mosaic for the mutation, so instead of genotyping these fish directly, the 
fish were bred individually with wild type fish and the embryos produced were genotyped in pools. 
In any pools with positive genotyping results, the remaining embryos in the clutch were reared. 
These fish were then fin clipped and sequenced to find the nature of the mutation. Ultimately, the 
genotyping method produced false positives and none of the F2 zebrafish examined had a 
mutation in dlk1 or dlk2.  
 
Genotyping methods 
When the experiment was started, it was the first of its kind to be performed in our facility and 
very early in the development of the CRISPR-Cas9 system. As such, there were no published 
genotyping methods for screening the mutations produced by the CRISPR-Cas9 system, only 
methodological studies. The first approach used was to amplify a 200bp PCR region spanning the 
CRISPR target site, with a restriction enzyme site within the guide sequence. A mutation occurring 
in the restriction enzyme site would cause failure of the PCR product to digest. Therefore, if any 
undigested PCR product remained, it would indicate that there is a mutation in the genomic DNA 
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within the target region. This approach did not identify mutations, and was assumed that it was 
because the restriction enzyme site might not always be the location of the mutation, which can 
occur around the guide site. The second genotyping method developed was a T7 endonuclease 
based approach. This approach had been described to work in identifying CRISPR mutations in 
Drosophila (unpublished;	 http://www.crisprflydesign.org/t7-endo-i-assay/). T7 endonuclease 
cleaves imperfectly hybridised DNA. After PCR of the region, T7 endonuclease is added to the 
reaction and any digestion is taken as an indication of a mutation. This technique proved 
inconsistent, often producing cleaved bands in wild type samples. The final genotyping method 
was using a high-resolution melting analysis. This technique had previously been described for use 
in identifying zebrafish mutations (Parant et al., 2009). Using this technique produced positive 
results. However, the genomic target regions of all fish with positive results from high resolution 
melting analysis were sequenced and these were ultimately found to be false positives and did not 
produce a mutant.   
 
 
4.3 Discussion 
 
MOs are the knockdown technology of choice and when appropriate controls are used they can 
yield useful results to examine the consequences of gene knock-down (Eisen and Smith, 2008). In 
addition to the appropriate controls, the gold-standard method of validating the MO phenotype 
is to rescue it by injection of the mRNA of the knocked-down gene. However, ubiquitously 
overexpressing the target gene by mRNA injection can lead to its own set of defects. This 
experiment was not preformed as there was concern over dosage effect, given that dosage is critical 
in the mouse system (Charalambous et al., 2012).  Also, efforts were redirected towards making 
stable genomic mutations on the assumption that this would validate the defects observed with 
the MO.  Off target effects are frequently seen in brain development, such as degeneration in the 
brain leading to ‘cloudy heads’, making interpretation of knockdown effects of genes expressed in 
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neuronal development particularly tricky. Due to these difficulties, it was determined that, in the 
case of determining the function of dlk1 and dlk2, it was not scientifically justified to develop this 
approach further. Therefore, the MO data shown here is somewhat preliminary. However, the 
later developed DLK2 antibody demonstrated a reduction in DLK2 protein levels. This 
strengthens the inclusion of MO data in this thesis to further our understanding of dlk2 function. 
 The novel knockout technology, CRISPR, was only first reported in early 2013 at the start 
of this project, with no existing experience of using this technology within the lab (Le Cong et al., 
2013). Experiments were performed using guide RNAs targeting the Albino locus that 
demonstrated successful knock-out by pigmentation loss. However, no dlk1 or dlk2 mutants were 
identified during the course of this project. One limitation of the CRISPR technology in targeting 
dlk1 and dlk2 is that the genomic sequence of these genes contains very few PAM domain 
sequences which are a necessary part of the guide RNA sequence design. In particular, the section 
of dlk2 that was targeted was highly GC rich, which leads to difficulties in genotyping and PCR 
errors caused by this are very likely to be a source of false positives in genotyping.  
 
4.4 Conclusion 
 
The production of a dlk1 and dlk2 mutant through CRISPR-Cas9 mediated genome editing was 
not possible in the time span of this thesis. At the point that the genotyping method was 
successfully and consistently in place, and the false positive mutants had been successfully ruled 
out, there was no longer time in the project to generate a new mutation. While zebrafish have rapid 
embryogenesis, the generation time (time to maturity) is still 3 months. This means that generating 
a stable mutation can take upwards of a year and, depending on the level of backcrossing 
determined to be necessary in order to remove off-target mutations, can take even longer. 
Transcription activator-like effector nucleases (TALENs) were not used in this project because, at 
the time, it was considered to be the inferior genome editing technology.  This was largely because 
of the increased time in producing the specific targeting plasmid and what was then believed to be 
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less efficient genome editing rates. If dlk1 and dlk2 mutant zebrafish are to be attempted again in 
the future, TALENs could be a better option because they would be less limited in where they can 
target within these genes. It is also becoming increasingly clear that different guide RNAs and 
different genes have vastly different efficiencies of mutation and off-target effects with CRISPR 
technology (Wu et al., 2014). Unpublished data within the lab shows that targeting Dlk2 with 
CRISPR in mouse has been similarly unsuccessful so far, while other genes targeted with the 
identical technique have had very high levels of success (pers. comm. Anne Ferguson-Smith). 
However, efficiency of CRISPR-Cas9 mediated genome editing is constantly progressing and it 
may well be worth attempting it again in the future (Burger et al., 2016).  
 The MO study demonstrated that Dlk2 protein was reduced, and even with the difficulty of 
off-target effects, this could still be a useful tool for examining dlk2 function in the future. One 
possibility is to use splice-site blocking MOs instead of the translation blocking ones used in this 
study, as they allow direct validation of knockdown through analysis of the mRNA. The second 
possibility is to use the photo-cleavable MO for a targeted knockdown in specific locations 
(Sumanas, 2017; Tallafuss et al., 2012).     
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5. Analysis of dlk2 mutant zebrafish. 
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5.1 Introduction 
	
 
To understand the function of the ancestral dlk2 gene, examination of a mutant zebrafish was 
essential. Unfortunately, the efforts to produce a mutant during this project were unsuccessful, as 
described in Chapter 4. However, during the course of this project, a dlk2 mutant became available 
from the Zebrafish Mutation Project. The mutation occurs in an essential splice site at the 
beginning of exon 4 (Fig. 5.1). Exon 4 contains multiple EGF repeats and exon 5 contains the 
trans-membrane domain. Aberrant splicing at the start of exon 4 is predicted to result in a 
nonsense transcript and premature truncation of this gene before exon 4. This is predicted to result 
in a null mutation, as the EGF repeats and transmembrane domain are thought to be essential for 
Dlk2 function (Fig. 5.1).  
 The purpose of this study was to examine the dlk2 mutant zebrafish to understand the 
function of this gene in zebrafish development, as well as to provide model systems that can be 
examined to understand the mechanism by which this gene operates. This chapter describes the 
characterisation of the dlk2 mutant zebrafish, with the aim of identifying aberrant developmental 
features that demonstrate the functional role of dlk2 and to provide a system in which to examine 
its function.  
 
5.2 Results  
 
5.2.1 dlk2 mutant from the Zebrafish Mutation Project has no detectable DLK2 protein 
using IHC with the DLK2 antibody.  
 
 
A DLK2 polyclonal antibody was generated in collaboration with Abcam, using the whole 
recombinant human DLK2 protein as the antigen. The antibody did not detect a band at the 
predicted molecular weight of zebrafish Dlk2 (42 kDa); however, whole mount IHC was 
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performed and produced a specific signal in the same locations as the dlk2 ISH (see section 3.x). 
Whole mount IHC was performed on wild type and dlk2 mutant zebrafish embryos (Fig. 5.2). At 
24 h.p.f., there was no signal at all from the Dlk2 IHC (Fig. 5.2B). At 5 d.p.f., there is a small 
amount of signal produced by the Dlk2 IHC in the dlk2 mutant (Fig. 5.2C). This signal is largely 
constrained to external surfaces, suggesting it is non-specific. However, there may be some weak 
cross-reactivity with similar proteins, such as Dlk1.  This result supports the prediction that there 
is no Dlk2 protein produced in the dlk2 mutant zebrafish. 
 
 
5.2.2 No gross morphological defects are observed in the embryonic development of dlk2 
mutants. 
 
Morphological analysis was performed on the embryos of the developing dlk2 mutants using a 
developmental checklist to identify possible defects. Murine Dlk1 mutants suffer from growth 
retardation, but no growth defects were found in the zebrafish mutants. No obvious defects were 
found in the morphology of the developing zebrafish (data not shown).   
 
 
5.2.3 dlk2 mutant larvae show a reduction in Notch signalling and an increase in the 
levels of GFAP protein 
 
 
The dlk2 mutation was bred into the Notch responsive zebrafish model. This transgenic zebrafish 
has a series of RBP-jk sites driving a fluorescent protein. These enhancer sites are bound by the 
Notch intracellular domain and its co-factors, so the fluorescent protein will be expressed 
wherever Notch signalling is active (Parsons et al., 2009).  These Notch-responsive dlk2 mutant 
embryos were examined. At 48 h.p.f. there is a reduction in Notch active signal in the embryonic 
brain (Fig. 5.3), consistent with the result observed with dlk2 morpholinos (Section 4.2). Whole 
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mount IHC was performed on the dlk2 mutant zebrafish using the GFAP antibody. At 48 h.p.f., 
there is a striking increase in GFAP protein in dlk2 mutant embryos (Fig 5.4). 
 
 
5.2.4 GFAP protein is depleted in larval stage dlk2 mutants.  
 
 
IHC was performed on hatching stage (72 h.p.f.) embryos and early larval stage (5 d.p.f.) zebrafish. 
The numbers of GFAP positive cells were reduced in the dlk2 mutant hatching embryos and 
almost completely absent in the larval zebrafish (Fig 5.5).  
 
 
 
5.2.5. Cell proliferation analysis 
 
In order to determine if the increase of GFAP protein was due to an increase in proliferation of 
cells that have high GFAP levels, or if the high levels of GFAP were independent of an increase 
in cell numbers, a BrdU analysis was performed (Materials and methods, 2.6). BrdU is incorporated 
into the DNA of cells that divide during the period of BrdU exposure (pulse period).  This 
becomes diluted by further cell divisions after BrdU washout (chase period).  Therefore, 
experiments were performed with collection and fixation of embryos immediately after BrdU 
washout. There were much higher levels of BrdU signal in the 48 h.p.f. dlk2 mutant zebrafish (Fig 
5.6E), and the BrdU was highly co-localised with the GFAP IHC signal (Fig. 5.6). This 
demonstrates that the neural progenitor cells have increased levels of proliferation at early stages 
and this cell population is subsequently depleted by the early larval stage. 
 
 
5.2.6. Behavioural analysis of larval zebrafish demonstrates that dlk2 mutant larvae have 
increased motility. 
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To examine the behavioural consequences of the over-proliferation and subsequent depletion of 
the neural progenitor cell population, tracking of the larval zebrafish was performed using multi-
well plate tracking apparatus. Initial examination (n=24) of dlk2 mutant larvae movement suggests 
that they have increased locomotion activity (Fig. 5.7).  A significant difference was found between 
the genotypes (F(1,132)=4.86, p=.029;  ANOVA). Dlk2 mutant zebrafish fish (M=4294.57px 
±960.26) travelled significantly more distance overall compared to control fish (M=2178.29 px 
±960.26). No significant time period ((MOVEM) (F(5,132)=.41, p=.842)), nor a time period x 
genotype interaction, (F(5,132)=.955, p=.448) was seen.  
 
5.2.7. Radial glia are absent in the telencephalon of adult dlk2 mutants. 
 
 
The radial glial cells in the adult telencephalon were identified as expressing dlk1 and co-localising 
with Dlk2 protein (Section 1.4). Therefore, radial glial cells were examined in the dlk2 mutant 
zebrafish to determine whether dlk2 was involved in their regulation. IHC was performed using 
the GFAP antibody, and found that in the dlk2 mutants, there were no GFAP positive cells in the 
periventricular zone (Fig 5.8). This demonstrates that the radial glial cell population is absent in 
the adult dlk2 mutant zebrafish telencephalon.  
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Figure 5.8 | The radial glial cell population is not present in adult dlk2 mutant zebrafish.  
A section from a wild type adult zebrafish telencephalon with GFAP IHC performed on it. The 
GFAP IHC show clear radial glial cell populations, as shown by arrows. B section from a dlk2 
mutant adult zebrafish telencephalon with GFAP IHC performed on it. The GFAP positive 
radial glial cells are not present. C A schematic diagram of the adult telencephalon section, with a 
diagram representing where the images A and B are located.  
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5.3 Discussion 
 
The aim of this chapter was to elucidate the function of dlk2 by examining the consequence of 
dlk2 mutation on the development of zebrafish embryos. The lack of signal observed following 
IHC with the Dlk2 antibody (Section 5.2.1) supports the prediction that the mutation produced 
by the Zebrafish Mutation Project results in a complete loss of Dlk2 protein. In wild type zebrafish, 
dlk2 was found to be highly expressed throughout the zebrafish brain using ISH analysis 
performed in Chapter 3, as well as in endodermally- and mesodermally-derived tissues. Therefore, 
it was predicted that the loss of dlk2 would lead to morphological and developmental 
abnormalities. Morphological examination of the dlk2 mutant embryos revealed that the embryos 
develop normally. No gross morphological abnormalities were detected. It is currently unknown 
what the effect of Dlk2 mutation would be in the mammalian system; however, Dlk1 mutation 
leads to growth retardation and obesity in mice (Moon et al., 2002). The lack of developmental 
abnormalities in the zebrafish could be due to differences in biology between mice and zebrafish. 
The growth retardation phenotype could be caused by misregulation of hormones not present in 
zebrafish. In this case, an obesity phenotype would not be observed, as the first adipose deposition 
occurs after 5 d.p.f., which occurs outside the scope of this investigation (Flynn et al., 2009). An 
alternative explanation is that dlk2 functions in zebrafish could be partially redundant; potentially, 
they could be compensated for by the activity of dlk1, which has a very similar expression pattern 
in early zebrafish embryogenesis. Another explanation is that there are differences in the functional 
roles of dlk2 in zebrafish and Dlk1 in mouse. 
 The neural progenitors were the focus of investigation for this study because of the strong 
dlk2 expression present throughout the zebrafish embryonic brain and the known role of murine 
Dlk1 in regulating NSCs (Ferrón et al., 2011). The co-localisation of BrdU signal and the increased 
GFAP protein levels supports the conclusion that the changes is GFAP levels are due to an 
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increase of cells with high GFAP protein levels. Further, the loss of Notch-activation signal can 
be hypothesised to be due to a reduction of cell numbers that express Notch signalling. From this, 
it was concluded that an initial loss of Notch-activated cells was observed with a concurrent 
expansion of the transit amplifying neural progenitor population through increased proliferation 
(Summary Fig 5.9). Later in development, the neural progenitor population is depleted. These 
results lead to the hypothesis that the premature and over-differentiation of the NSC population 
leads to a large increase in GFAP positive cells that terminally differentiate, most likely into primary 
motorneurons (Bingham et al., 2003). Later in development, there would be no NSCs left to 
produce the correct GFAP positive cell populations. However, it is possible that the changes in 
GFAP and Notch activity are due to cell autonomous expression changes rather than changes in 
cell numbers. This too could lead to changes in cell fate, which would account for the differences 
observed in the mutant.  
The dlk2 mutants also demonstrated increased levels of locomotion in a preliminary larval 
tracking study. This phenotype could be explained by increased specification of primary 
motorneurons, expected from the expansion of the early neural progenitor pool (Appel et al., 2001; 
Bingham et al., 2003). If this hypothesis is correct, it may lead to later neurological defects with a 
lack of the secondary motorneuron populations and glial cells, which are produced by the neural 
progenitors (Johnson et al., 2016). Further work examining the number of different cell types 
present and their population sizes could be performed to confirm this phenotype.  
 The final result presented in this chapter is the loss of radial glial cells in the adult 
telencephalon of the dlk2 mutant. It is unknown if this is because of a later aberrant specification 
of the radial glial population, or if these cells are derived from the cell populations missing in the 
dlk2 mutant. The radial glial cells in the adult telencephalon have been shown to be responsible 
for the regeneration occurring in response to injury of the telencephalon (Kroehne et al., 2011). It 
would be of great interest to examine the effect of a brain lesion assay in a system when the radial 
glial cells are missing, such as the dlk2 mutant zebrafish. In particular, it would be interesting to 
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examine whether other cell populations are able to take over the role of the radial glial population 
or whether regeneration will be impossible. Upon injury to the brain, there is an initial 
inflammatory response. In mammals, the inflammatory response is maintained, which leads to an 
environment that is not conducive to regeneration and a glial scar is formed. Zebrafish, on the 
other hand, are able to suppress the inflammatory response, promote a neurogenic environment, 
and are able to fully regenerate the injury (Baumgart et al., 2012). It would be interesting to examine 
the role of the radial glial cells in dampening the inflammatory response and in creating the 
environment that allows them to repopulate the injured site.  
 
 
5.4 Conclusion 
 
 
The ultimate aim of this project was to describe a model system in which the mechanisms of dlk2 
function can be elucidated. The role of dlk2 in the regulation of zebrafish embryonic neural 
progenitor populations is an ideal system. The results presented here suggest that dlk2 is involved 
in the regulation of these neural progenitor populations. The high similarity of phenotype between 
dlk2 mutation and aberrations in the Notch signalling pathway highly suggest that dlk2 operates 
via the Notch signalling pathway in this developmental context. This has not previously been 
demonstrated in an in vivo system and hence provides a tool for further detailed investigations.   
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6. Discussion 
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6.1 Introduction  
 
The purpose of this project was to establish a zebrafish model system to elucidate the mechanisms 
of dlk1 and dlk2 function. In order to achieve this, the aim was to answer the following questions: 
1) Where and when are dlk1 and dlk2 expressed during zebrafish development? 
a. How does this compare to the known expression of Dlk1 in murine development? 
b. Which cell populations expressing dlk1 and/or dlk2 could be used as model 
systems to examine their function? 
c. Where is dlk1 and dlk2 expression in relation to Notch signalling? 
2) What are the functional consequences of a dlk2 mutation? 
a. Are there any gross morphological phenotypes in dlk2 mutant zebrafish embryos? 
b. How are the model systems which normally express dlk2 affected by loss of its 
expression? 
c. How does the function of zebrafish dlk2 compare to that of murine Dlk1? 
In summary, the results presented in this thesis demonstrate that: 
i) Both dlk1 and dlk2 are expressed during zebrafish embryonic development. There are 
some similarities between the embryonic expression of dlk1 and dlk2 in zebrafish with 
the expression of murine Dlk1.  
ii) Zebrafish dlk1 and dlk2 are expressed in specific cell populations in the larval brain, 
which overlap with both Notch signalling and the GFAP positive radial glial cells 
responsible for generating neuronal populations. 
iii) Dlk1 is expressed in the radial glial cells of the adult telencephalon. The DLK2 
antibody shows localisation of DLK2 protein in the radial glial cells. These cells are 
known to be regulated by Notch signalling. 
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iv) Loss of dlk2 does not lead to any observed gross morphological phenotypes in the 
developing zebrafish embryo. 
v) Loss of dlk2 leads to early, rapid, cell division of the embryonic radial glial cells, causing 
a subsequent depletion of this cell population by 5 d.p.f. Preliminary evidence suggests 
this leads to behavioural abnormalities, which may be due to the incorrect specification 
of mature neuronal populations as a result of the disruption of the radial glial 
population. 
vi) Dlk2 mutants do not have the normal radial glial cell population in the adult 
telencephalon.  
 
The differences between the expression of dlk1 and dlk2 in zebrafish and Dlk1 in mouse may be 
due to differences in the functions of these genes between the two species. In particular, zebrafish 
dlk1 and dlk2 maintain high levels of expression throughout the developing brain, whereas mouse 
Dlk1 becomes localised to just a few cell populations early in development. This may be due to 
evolutionary differences in the roles that dlk1 and dlk2 play in zebrafish development compared 
to the role of Dlk1 in mouse. The more abundant expression pattern observed in zebrafish 
compared to mouse may represent an ancestral role of the genes or it may be representative of the 
difference in neurobiology between the two species. Zebrafish maintain much higher levels of 
neurogenesis throughout the developing embryo and in the adult brain (Paridaen and Huttner, 
2014).  The suggested role of dlk1 and dlk2 in regulating these neurogenic cell populations may 
explain the broader expression domain of dlk1 and dlk2 in the zebrafish brain. 
 The presence of dlk1 and dlk2 in both embryonic and adult radial glial populations, as well 
as the abnormal regulation of these populations in the dlk2 mutant zebrafish, ultimately suggests 
that dlk1 and dlk2 are involved in the regulation of stem cell populations, as described in mouse.  
Therefore, this study demonstrates that zebrafish is an excellent model system to examine the 
mechanistic function of dlk1 and dlk2, and it is likely that they operate through the same 
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mechanisms to regulate stem cell populations as observed in the murine system. Elucidating the 
mechanisms and signalling pathways that zebrafish dlk1 and dlk2 are operating through were 
beyond the scope of this study. However, the model system established produces a system that is 
available for further examination and will elucidate the mechanisms of dlk2 function in zebrafish.  
 
6.2 dlk1 and dlk2 expression in zebrafish and comparison to murine Dlk1 
 
Comparing the embryonic development of mouse and zebrafish is inherently challenging. They 
are two very different organisms, with different life history traits, separated by hundreds of millions 
of years of evolution. Here it was demonstrated that dlk1 and dlk2 are expressed in zebrafish 
embryonic development, as Dlk1 has previously been described in murine embryonic 
development. In addition, like murine Dlk1, zebrafish dlk1 and dlk2 are expressed in cells derived 
from all three germ layers (da Rocha et al., 2007; Yevtodiyenko and Schmidt, 2006). Dlk1 in mouse 
is associated with numerous mammalian specific processes, being expressed in extra-embryonic 
tissues, and is also associated with the mammalian transition to independent life, including 
processes involved in thermoregulation (Charalambous et al., 2012; da Rocha et al., 2007). These 
structures and processes are fundamentally different and unique to mammals, hence there are no 
homologous tissues or physiological processes that could be examined in zebrafish. One of the 
most striking differences between mouse and zebrafish is the broad expression of dlk1 and dlk2 
throughout the embryonic brain, whereas murine Dlk1 is isolated to just a few locations in the 
embryonic brain (da Rocha et al., 2007). Murine Dlk1 has been demonstrated to be a stem cell 
regulator (Section 1.4). In mouse embryogenesis, NSC pools get restricted to isolated zones, in 
particular to the ventricular zone and the subventricular zone (Zhang and Jiao, 2015). In zebrafish, 
on the other hand, the brain has many more sites of neurogenesis (Schmidt et al., 2013). Therefore, 
the broader expression of dlk1 and dlk2 throughout the embryonic brain may purely be 
representative of the additional levels of neurogenesis and NSC populations, rather than a 
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difference in function between these genes in mouse and zebrafish. However, preliminary studies 
of Dlk2 expression in murine embryos show expression in post-mitotic neurons (pers. comm. 
Alex Ashcroft, Fig. 1.13). This is suggestive that there may be an additional function in the brain 
that could be ancestral and has been lost by murine Dlk1 during the process of it being co-opted 
into mammalian specific processes.  
Fundamentally, the aim of studying dlk1 and dlk2 expression in zebrafish development was to 
identify areas of expression and to use these areas of known expression for experimental study. It 
was shown that dlk1 and dlk2 are expressed in the region of neural progenitor populations and 
that the regulation of these cell populations is perturbed in dlk2 mutants. This evidence suggests 
that dlk2 is a stem cell regulator, just like Dlk1 in mouse. It also suggests that the differences in 
expression in the brain are, at least in part, to do with the differences in neurobiology between the 
two organisms rather than a difference in function between the genes.  Further study of murine 
Dlk2 will help elucidate potential roles these genes might have in post-mitotic neurons. The 
zebrafish will remain an excellent model to further examine these functions (Section 6.5.1).   
 
6.3 Function of dlk2 in zebrafish  
 
One of the aims of this study was to examine the role of dlk2 in zebrafish development, with the 
ultimate aim of understanding the mechanisms by which dlk2 operates. Dlk2 represents the 
ancestral form of the dlk1 and dlk2 genes (Section 1.2). Therefore, understanding the mechanisms 
by which dlk2 functions in zebrafish will give great insight into the functional mechanisms of this 
gene family as a whole and throughout the chordate phylum. This study morphologically described 
the dlk2 mutant zebrafish and provided a model system in which to further examine the functional 
mechanisms of this gene. Combining the results of this project with existing literature has provided 
evidence for a model of dlk2 mechanistic function in NSCs in the developing zebrafish brain, 
which is likely mediated through the Notch signalling pathway. These findings open up new 
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avenues for further research into regulation of neurogenesis and mechanisms of adult 
regeneration.  
 
 
6.3.1 Morphological examination of dlk2 
 
The mouse Dlk1 mutation that has been described is a homozygous viable mutation (Moon et al., 
2002). However, the Dlk1-null mouse does have gross morphological differences from that of wild 
type siblings. The most obvious differences are the increased fat deposition and growth retardation 
(Moon et al., 2002). Fat deposition in mouse embryos and neo-natal mice is much more apparent 
than in zebrafish. Post-natal mice must be able to regulate their own body heat and the fat reserves 
are extremely important for their thermogenesis (Rugh, 1968). Zebrafish, on the other hand, are 
thermoregulated by the temperature of the water they live in. The earliest signs of adipogenesis in 
the zebrafish are at 8 d.p.f., with fat droplets forming in the viscera (Flynn et al., 2009). The present 
study examined the embryonic development up to 5 d.p.f., so there may be adipogenesis defects 
occurring at time points that were not examined in this study.  This could be an interesting future 
area of study (Section 6.6.3), as zebrafish is increasingly being considered as an adipogenic model 
with common pathophysiological pathways to mammals (Flynn et al., 2009; Oka et al., 2010). No 
apparent growth retardation was found in the dlk2 mutant zebrafish. This could be because of the 
different roles of dlk1 and dlk2, or perhaps due to the different physiology of the development of 
zebrafish relative to that of mouse. Another possibility is that the growth effects are impossible to 
identify because of the large variation in juvenile zebrafish size in normal conditions (Mabee et al., 
2009). The variations in growth size can come from environmental factors such as density of 
animal stocking. However, they can also arise from the greater genetic background effects as 
zebrafish lines are far less inbred than the mouse lines used to examine the Dlk1 mutation.  
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With this information in mind, it is potentially not surprising that morphological 
phenotypes that could be caused by dlk2 mutation were not discovered in this study. There is a 
considerable difference in adipose development between the species, where adipose tissue is 
present at earlier mouse embryonic stages than zebrafish embryonic stages. In zebrafish, 
adipogenesis occurs outside of the developmental stages examined in this study, and size variation 
may be masked by genetic background effects. 
 
6.3.2 Model of dlk2 function in the embryonic neural progenitor cells 
 
The dlk2 mutation was bred into a Notch-responsive transgenic zebrafish in which a fluorescent 
protein is expressed where Notch signalling is active.  Different embryonic time points were 
examined and co-localisation of the Notch signal with GFAP-positive cells (labelled by IHC) was 
examined. At 48 h.p.f., there was a large increase of GFAP positive cells not present in the wild 
type. BrdU staining confirmed that, at 48 h.p.f., these cells where highly proliferative, with the 
BrdU signal clearly co-localising to the GFAP positive cells. By 72 h.p.f., the pool of GFAP-
positive cells was depleted relative to the wild type embryo. By the early larval stage there were 
almost no GFAP-positive cells in the mutant larvae, while there is a large number present in the 
wild type larvae. The exact nature of the GFAP-positive cells at this embryonic stage is not 
perfectly defined, but they are generally referred to as neural progenitors, radial glial cells or 
oligodendrocyte precursor cells (Appel et al., 2001; Zaucker et al., 2013). It is likely that they are a 
transit amplifying population, derived from NSCs derived from the developing neural epithelium. 
Early defects in neurogenesis have been identified previously in Notch mutants, such as mind bomb, 
which encodes E3 ubiquitin ligase required for effective Delta function (Bingham et al., 2003). 
Notch3 zebrafish mutants also have reduced numbers of GFAP expressing cells at 52 h.p.f., which 
is a very similar phenotype to the dlk2 mutant described in this thesis (Zaucker et al., 2013). This 
same neurogenic defect in zebrafish larvae has been described in a dominant negative mutation of 
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deltaA  (Appel et al., 1999). In addition, behavioural deficits have previously been reported in the 
Notch-signalling perturbed mutants due to the increase in primary motorneurons at the cost of 
later-specified secondary motorneuron populations (Appel et al., 2001; Bingham et al., 2003). The 
similarity in phenotypes between the Notch-signalling perturbed mutants and the dlk2 mutant 
described strongly supports the hypothesis that dlk2 operates through the Notch signalling 
pathway in this context. In the existing literature, the hypothesis for the role of dlk2 in the Notch 
signalling pathway is  as an inhibitor of Notch, because it lacks essential Notch ligand binding 
domains (Bray et al., 2008).   
 In summary, the current model is that the NSCs in the early zebrafish embryo are regulated 
through lateral inhibition of Notch signalling. Small asymmetries in Notch activation in the 
heterogeneous NSC population are reinforced by expression of Delta in differentiating cells (low 
Notch signalling cells), in order to maintain high levels of Notch in the neighbouring cells. This 
balance between Notch and Delta signalling is the mechanism that maintains the NSC pool and 
controls the correct timing of differentiation of the transit amplifying cell populations, such that 
they receive the correct signalling information from other pathways and are specified into their 
correct neuronal fate (Appel et al., 2001).  The results presented here could be interpreted as dlk2 
behaving as a Notch-activating ligand in the zebrafish embryonic brain, explaining the same 
phenotype in dlk2 mutants as in Delta and Notch mutants. However, another hypothesis is that 
dlk2 is behaving as a dominant negative Delta or a Delta antagonist. In this hypothesis, dlk2 is 
operating to establish heterogeneity in Notch-signalling in the NSC populations, which facilitates 
the lateral inhibition mechanisms of the NSC fate regulation. If, in the wild type scenario, Notch 
is not correctly down-regulated in cells fated to differentiate, it could lead to a lack of Delta up-
regulation in the few cells meant to differentiate. Therefore, high Notch signalling in the 
neighbouring cells would not be maintained, which in turn leads to abnormally high numbers of 
cells prematurely differentiating and a depletion of the stem cell pool. The results described in this 
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project are not sufficient to determine which of these two models is correct. Future experiments 
will need to be performed in order to elucidate the mechanism of dlk2 function (Section 6.5.3).  
 
6.4 Consequences of lacking adult radial glial cells in the telencephalon 
 
The radial glial cells in the periventricular zone of the adult zebrafish telencephalon are known to 
play an important role in the regeneration of the brain upon injury (Baumgart et al., 2012; 
Chapouton et al., 2010; Kroehne et al., 2011). This study demonstrated that dlk2 mutant zebrafish 
lack this cell population in the adult telencephalon. Similarly, adult mammalian brains do not have 
NSCs capable of regenerating following brain injury. When a brain injury occurs in mammals, 
there is a major inflammatory response, which activates microglia and macrophages. This results 
in a wave of neural degeneration, negative regulation of neurogenesis, and the formation of a  glial 
scar (Ekdahl et al., 2003; Fitch and Silver, 2008; Silver and Miller, 2004). In zebrafish, there is an 
initial inflammatory response but it very quickly subsides, allowing for an environment that is 
permissive to neurogenesis and regeneration (Kroehne et al., 2011). 
  The dlk2 mutant zebrafish can be used as a model to understand the response to injury in 
the adult telencephalon when the radial glial cells are absent. It would aid in understanding the 
responsibility this cell population has in regeneration, and whether regeneration is possible without 
it. In addition, the dlk2 mutant zebrafish models opens up the possibility of understanding whether 
there is a permissive neurogenic environment even without radial glial cells, or if the inflammatory 
response is overwhelming in the absence of the NSCs responsible for re-populating the injury site, 
leading to scar formation. Understanding this process would be informative in understanding how 
to generate such regeneration-permissive environments within mammalian brains. In order to 
address such questions, a targeted ablation model, using the GFAP promoter, has been created 
(Shimizu et al., 2015). However, this approach is not completely effective at removing the radial 
glial cells. In addition, the ablation of all cells expressing GFAP will, most likely, have secondary 
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effects beyond just losing this cell population, which may confound the analysis of the radial glial 
cells in the regeneration process.   
 
6.5 Future work 
 
6.5.1 Dlk2 in mouse  
 
During this thesis, both dlk1 and dlk2 in zebrafish have been compared to Dlk1 expression in 
murine development. Dlk1 has been extensively studied in murine development and different stem 
cell populations. On the other hand, there has been very little descriptive or experimental work 
performed on Dlk2, and no in vivo examination. The aim of this study was to produce a model to 
understand the basal mechanism of operation of these genes; therefore, the justification for 
focusing on zebrafish dlk2 and its comparison to murine Dlk1 is two-fold: 
i) The structural similarity between murine Dlk1 and Dlk2 is very high, suggesting a shared 
mechanistic operation. This would be similar to the reasonable assumption that different 
canonical Delta genes would operate through the same Notch-based mechanisms (such as dll1, 
dll2 and others.). 
ii) Evolutionary analysis suggests that Dlk2 is the ancestral gene, from which Dlk1 was derived. 
Its sequence is much more highly conserved than Dlk1. This leads to the second assumption, 
which is that zebrafish dlk2 function, particularly if shared with murine Dlk1 function, is 
representative of the basal mechanism of function for these genes.  
However, understanding the role of murine Dlk2 would be extremely useful to make a thorough 
comparison between the two organisms. There is on-going work in the lab to describe the 
embryonic expression of murine Dlk2 and to produce a Dlk2 mutant mouse using the CRISPR-
Cas9 technique (pers. comm. Alex Ashcroft). Initial Dlk2 ISH analysis of mouse embryos show 
broad expression in the brain. This is similar to dlk1 and dlk2 expression in zebrafish embryos, 
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supporting the hypothesis that zebrafish dlk1 and dlk2 represent the ancestral functions of this 
gene family.   
 
6.5.1 Further investigation of the phenotype of dlk2 mutants 
i) In depth exploration of the consequences of dlk2 loss for embryonic NSC 
The first question that needs to be addressed is whether the expansion of the transit 
amplifying GFAP-positive cell population is due to the premature differentiation of the 
earlier NSCs derived from the neural epithelium. The Notch-responsive reporter is a good 
model for gross Notch signalling examination, but not the best system for examining the 
fine details of these cell populations. Antibodies for Her6 and Sox2 would be ideal for 
examining the initial NSC population. Antibodies for DeltaA and Neurog1 would identify 
the cells that are beginning to differentiate (Schmidt et al., 2013). Using these markers will 
give a more precise understanding of the effect that the loss of dlk2 has on these NSC 
populations.	
ii) Behavioural analysis of dlk2 mutant zebrafish 
Preliminary results from the tracking of larvae zebrafish have suggested that the early larval 
dlk2 mutants have increased levels of movement under normal conditions. This could be 
examined further by investigating the response of the larvae to a vibration stimulus, which 
is known to evoke a startle response, and their ability to habituate to this stimulus. The 
hypothesis is that this behavioural phenotype is due to the increase in primary 
motorneurons, and that lack of secondary-born motorneurons may lead to later 
behavioural defects that can be further examined using markers for the different neuronal 
types. The markers that can be used are outlined in previous studies (Appel et al., 2001; 
Bingham et al., 2003). Of particular interest would be isl1, a marker for presumptive 
primary motor neurons, and the zn-8 antibody, which is a marker for secondary motor 
neurons (Appel et al., 2001).  
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iii) Further examination of the mechanism of dlk2 function 
This thesis has produced a model system in which to examine the mechanism of dlk2 in 
zebrafish. However, it currently does not provide sufficient evidence to determine this 
mechanism. The results demonstrate that dlk2 mutant zebrafish have aberrant 
specification of NSCs in the embryonic brain. This leads to premature differentiation of 
these cells and in the subsequent depletion of this cell population. This same phenotype is 
also observed in Delta and Notch mutants (Appel et al., 1999; Appel et al., 2001; Bingham 
et al., 2003; Zaucker et al., 2013). From the results obtained to date, it is not possible to 
determine whether dlk2 is operating as a Notch-activating ligand or a Notch antagonist.  
In order to examine this, a targeted knock-down or knock-out in the NSC of dlk2 could 
be performed. Notch signalling in adjacent cells should then be observed and ultimately 
these could be lineage traced to determine the role of dlk2. This could be performed by a 
conditional dlk2 mutant, using a Cre recombinase approach (Ni et al., 2012). Alternatively, 
a photo-cleavable morpholino (MO) approach could be used. Combination of a photo-
sensitive moiety into the MO structure allows the MO to be either activated or inactivated 
by UV photolysis (Sumanas, 2017; Tallafuss et al., 2012).  Since the results presented in 
Section 2.3 show that dlk2 MO injected zebrafish do have a reduction in DLK2 protein, 
further studies could be performed using photo-activatable forms of the dlk2 MO. This 
would allow both temporal and spatial knock-down of dlk2 in targeted NSC(s), followed 
by the examination of the Notch signalling in adjacent cells and would eliminate the 
confounding effects of knockdown on earlier developmental events.  
 
iv) The role of dlk2 in zebrafish adipogenesis  
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Murine Dlk1 has been shown to inhibit the differentiation of pre-adipocytes into mature 
adipocytes (Sul, 2009). In addition, an obesity phenotype is described in the Dlk1 mutant 
mouse (Moon et al., 2002). Zebrafish has been studied as a model for adipogenesis and 
obesity (Flynn et al., 2009; Oka et al., 2010). It would be interesting to examine the 
histology and development of the adipose tissue  in the dlk2 mutant to examine if it has a 
role in adipogenesis, similar to the role of murine Dlk1 and also that hypothesised for 
murine Dlk2 (Nueda et al., 2007). 
 
6.5.4 Dlk1 in zebrafish 
 
During this thesis, an attempt was made to modulate dlk1 in zebrafish using MOs and to produce 
a dlk1 mutant using the CRISPR-Cas9 technology. Unfortunately, neither of these attempts were 
successful and a zebrafish dlk1 model has not been established. It would be hugely beneficial to 
the understanding of dlk1 to produce a zebrafish mutant at this gene locus. An attempt has been 
made to produce a null mutation of Dlk2 in mouse using CRISPR-Cas9 and it is proving equally 
difficult, even though other genes were targeted at the same time and have been successful (Data 
not published, pers. comm. Anne Ferguson-Smith). This suggests that these genes may be 
particularly hard to mutate using the CRISPR-Cas9 system. However, TALENs have been 
successfully employed for targeted mutation in zebrafish and these could be used to attempt to 
mutate the dlk1 gene locus (Zu et al., 2013).  
 
6.5.5 Examination of the role of radial glial cells using a model that has no radial glial 
cells.  
 
The radial glial cells in the periventricular zone of the adult zebrafish telencephalon have been 
shown to be responsible for the regeneration of the telencephalon upon injury (Kroehne et al., 
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2011).  What would occur in a system where there is no radial glial cell present when the injury 
occurs is currently not known. The established brain stab model could be employed to assess this 
(Baumgart et al., 2012). In this model, the adult zebrafish are stabbed with a needle through a 
nostril into one lobe of the telencephalon. The lesion created is then examined in a time series 
from the time of injury. Of particular interest, this experiment would examine whether 
regeneration is still possible and whether other cells would fill the role of radial glial cells. 
Furthermore, the experiment could show whether the inflammation response, which leads to glial 
scars in mammals, would be as limited as usual or if the presence of the radial glial cells is essential 
for promoting a regenerative environment (Baumgart et al., 2012). 
 
In summary, the present study has shown that zebrafish are a valuable model to investigate the 
ancestral functions of dlk1 and dlk2.  The discovery that dlk2 loss of function results in an absence 
of adult radial glia cells reveals an important role for this protein in the regulation of zebrafish 
NSCs.  This study has identified a novel model that could be used to explore the role of radial glial 
cells in regeneration and may lead to important discoveries as to the role and mechanistic functions 
of the Dlk1 and Dlk2 genes. 
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